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My motivation for this thesis developed as I stumbled upon the Wender Utah Rating 
Scale (WURS). As a recent clinical psychology graduate, I had certain expectations 
about psychiatry diagnoses in general and the diagnosis of Attention Deficit 
Hyperactivity Disorder (ADHD) in particular. I thought for instance first and 
foremost that ADHD was a disorder of childhood, not appreciating it as a potentially 
persistent disorder, also affecting adults. I also supposed that the clinical phenomenon 
of ADHD would be sufficiently contained by the diagnostic symptom criteria set 
forth by the Diagnostic and Statistical Manual of Mental Disorders (DSM) or the 
International Classification of Diseases (ICD) diagnostic manuals. Thus, entering the 
adult ADHD project and stumbling upon the WURS that had been used for decades 
to retrospectively assess childhood symptoms of ADHD, I was taken by surprise by 
the apparent lack of face validity of this symptom checklist. Sure, there were 
questions of inattention in there, and some regarding hyperactivity/impulsivity as 
well. However, the main bulk of the 25 questions posed differed markedly from the 
18 symptom criteria of inattention and hyperactivity/impulsivity of the DSM system. 
Thus, my curiosity was lit, and I was looking into a horizon that was already broader 
than the two main diagnostic systems in the field would have me think.  
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Abstract 
Background/Introduction: Attention Deficit Hyperactivity Disorder (ADHD) is a 
prevalent condition in both children (estimated prevalence of about 5%) and adults 
(estimated prevalence of about 3%). ADHD is characterized by impairing symptoms 
of inattention and hyperactivity/impulsivity. However, there are at least two caveats 
to this symptomatic description. First, as ADHD was initially considered a childhood 
disorder, these symptoms and their conceptualization may be more applicable to 
children than adults. Second, ADHD in children, adolescents and adults is comorbid 
in up to 75% of cases, and can also be understood as an underlying broad regulatory 
deficit, spanning multiple symptom domains. Thus, to understand and adequately 
address the needs of adult ADHD patients there is a need to go beyond the core 
symptoms of ADHD and investigate frequently associated and impairing symptom 
domains.  
Aims: The overall aim was to investigate symptom domains in adults with ADHD 
including and expanding upon the core symptoms described in the Diagnostic and 
Statistical Manual of Mental Disorders (DSM).  In the three papers the thesis 
investigates 1) the psychometric properties and the clinical utility of self-reported 
childhood symptoms versus current symptoms using two frequently used symptom 
checklists for adult ADHD; 2) the prevalence and clinical correlates of insomnia in 
adult ADHD; and 3) the genetic components of aggressiveness in ADHD. 
Materials and Methods: This thesis is based on three separate papers. Paper I and II 
included 268 and 646 clinically diagnosed adult ADHD patients, respectively, as well 
as 202 and 908 population controls from the Medical Birth Registry of Norway, 
respectively. Paper III included a total of 1060 adult ADHD patients from three sites 
within an international multi-centre persistent ADHD collaboration (IMpACT): 
Germany, Norway, and Spain; and 750 adolescents with ADHD participating in the 
International Multicentre ADHD Genetics (IMAGE) study across Europe. 
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In Paper I we compared the Adult ADHD Self-Report Scale (ASRS) with the Wender 
Utah Rating Scale (WURS), testing the discriminatory ability for detecting and 
separating clinical ADHD patients from population controls. We used Receiver 
Operating Characteristics Area Under the Curve (AUC), Diagnostic Odds Ratio 
(DOR) and Likelihood Ratio (LH) as these methods are independent of the disorder 
prevalence in the sample studied. Principal Component Analysis (PCA) was used to 
validate the checklists. 
In Paper II we used the Bergen Insomnia Scale (BIS) to measure insomnia and the 
Adult ADHD Self-Rating Scale (ASRS) to assess ADHD symptom domains.  
In Paper III we performed a Genome Wide Association (GWA) study of a childhood 
aggressiveness phenotype in the adult ADHD sample, and compared this with GWA 
signals of dimensions of oppositionality (defiant/vindictive and irritable dimensions) 
in the adolescent sample.  
Results: In Paper I we found that both symptom checklists had excellent screening 
properties, with the WURS having an AUC of .96, (95% CI: .95-.97) and the ASRS 
an AUC of .90, (95% CI: .89-.92). The WURS factors Learning and Attention 
Problems and Aggressiveness and Social Problems were found to be the strongest 
discriminants of ADHD.  
In Paper II we found that insomnia was far more frequent among adults with ADHD 
(66.8%) than in a representative control sample (28.8%) (P < 0.001). Insomnia was 
more common in adults with the combined subtype of ADHD than in those with the 
inattentive subtype (79.7% and 55.6%, respectively) (P = 0.003). For self-reported 
current ADHD symptoms, inattention was strongly correlated to insomnia. Patients 
currently using stimulant treatment for ADHD reported a lower total insomnia score 
compared to patients without medication (P < 0.05). 
In Paper III no single polymorphism reached genome-wide significance (P<5.00E-
08). However, we did identify a number of biologically interesting markers (our top 
hits were rs10826548 within a long noncoding RNA gene; closely followed by 
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rs35974940 in the neurotrimin gene). As these markers possibly represent biological 
systems involved in childhood aggressiveness, they provide targets for further genetic 
explorations of aggressiveness across psychiatric disorders.  
Conclusions: The results in the present thesis suggest that we need to broaden our 
approach and scope when investigating and treating patients with ADHD. We need to 
move beyond the classic symptom domains of inattention, hyperactivity and 
impulsivity, and recognize that patients meeting criteria for the ADHD diagnosis tend 
to also have other impairing problems across different symptom domains. These 
domains, such as aggressiveness and insomnia, need to be addressed in order to 
adequately aid adult ADHD patients’ function in their daily life.  
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1.1 A brief history of Attention Deficit Hyperactivity 
Disorder 
Attention Deficit Hyperactivity Disorder (ADHD) is defined in the Diagnostic and 
Statistical Manual of Mental Disorders (DSM) (American Psychiatric Association, 
2013) by its symptoms of inattention, hyperactivity and impulsivity. These symptoms 
need to have a childhood onset, be impairing in two or more settings and not be better 
explained by other disorders (see Table 1). The diagnosis known as ADHD today had 
its formal beginnings with the name Hyperkinetic Reaction of Childhood in DSM-II. 
The name changed into Attention Deficit Disorder with or without Hyperactivity in 
the DSM-III (Wender, 1995). The ICD-10 still operates with the term Hyperkinetic 
Disorder (WHO, 1992), whereas the DSM-IV onward has named the disorder ADHD 
(American Psychiatric Association, 1994), and this is how it is most commonly 
known and researched to this day.  
Going back in time, the phenomenon underlying the current diagnosis of ADHD, 
despite varying names, has a long history. This history dates back in the medical 
literature at least to a 1775 medical textbook by the German physician, Melchior 
Adam Weikard (Barkley & Peters, 2012). The Scottish physician Alexander Crichton 
described disorders of attention in his medical textbook dating back to 1798. The 
German psychiatrist Heinrich Hoffman wrote poems about Fidgety Phil in 1865. The 
English pediatrician George Still wrote medical papers describing a phenomenon 
closely related to today’s conceptualization of ADHD in children in 1902, addressing 
the underlying behavioral problems as a moral deficit (Barkley & Peters, 2012). As a 
side note, Weikard himself “believed that people were more attentive in earlier times 
and less attentive in his time” (Barkley & Peters, 2012), a testament perhaps to 
human attention and point of reference, that we’re all operating in the context of our 
own history and experiences. Regardless, it seems safe to say that distractibility has 
been a hallmark symptom of the disorder since its modern inception (Barkley & 
Peters, 2012). George Still emphasized passion, or emotional lability as we would 
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probably label it today, as the most common and noteworthy attribute among all the 
features of the disorder (Barkley & Peters, 2012). This is an important point that will 
be discussed later, as emotional dysregulation has never been fully recognized as part 
of the official core criteria of the ADHD (Barkley, 2017). 
As previously mentioned, the concepts behind, the criteria for, and the names of the 
syndrome of Attention-deficit Hyperactivity Disorder have been changed several 
times. Prior to the third edition of the American Psychiatric Association’s Diagnostic 
and Statistical Manual of Mental Disorders (DSM-III, APA, 1980), the syndrome was 
conceptualized as composed of behavioral, motor, “perceptual”, and cognitive 
impairments (Wender, 1995). What is now conceptualized as ADHD was variously 
designated as “minimal brain dysfunction”, “hyperkinesis”, and the “hyperactive 
child syndrome”. The behavioral and cognitive abnormalities associated with the 
syndrome included, but were not limited to, overactivity, inattentiveness and 
distractibility, impulsivity, affective lability and moodiness, temper outbursts, 
“immaturity”, poor peer relations, disobedience, defiance, hostility, “acting out” or 
delinquent behaviors, and dyslexia and other learning problems. (Wender, 1995). 
DSM-III separated a cluster of symptoms from this potpourri which it designated as 
“Attention Deficit Disorder” (ADD), and grouped other behavioral problems under 
the category of “Conduct Disorder”. DSM-III stated that the “essential features are 
signs of developmentally inappropriate inattention and impulsivity” (Wender, 1995). 
Hyperactivity was acknowledged as being frequently present (ADD-H) but not 
essential for the diagnosis. The identification of ADD as a diagnosis that might or 
might not be associated with hyperactivity avoided a former oxymoron or linguistic 
problem – that of the non-hyperactive “hyperactive child”. The (frequently) 
associated features “vary as a function of age and include obstinacy, stubbornness, 
negativism, bossiness, bullying, increased mood lability, low frustration tolerance, 
temper outbursts, low self-esteem, and lack of response to discipline” (Wender, 
1995). In addition, Specific Developmental Disorders, i.e. learning disorders, were 
found to be common. Conduct Disorder was considered a “complication” (Wender, 
1995). 
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What was originally part of the same symptom cluster in the age of “minimal brain 
dysfunction” was split into separate categories of “attention deficit disorder” (ADD) 
(with or without hyperactivity) and “Conduct disorder” in the DSM-III (Wender, 
1995). ADD was renamed Attention-deficit Hyperactivity Disorder (ADHD) with the 
DSM-III-R, under the revised assumption that hyperactive/impulsive symptoms were 
most often present (no subtypes were listed) (Hinshaw & Scheffler, 2014), and 
ADHD was classified together with Conduct Disorder and Oppositional Defiant 
Disorder as a member of “Disruptive Behavior Disorders” (Wender, 1995). The 
DSM-IV changed the name of the disorder to Attention-Deficit/Hyperactivity 
Disorder, opening up for inattentive, hyperactive-impulsive and combined subtypes. 
The DSM-IV also changed the disorder category to “Attention-Deficit and Disruptive 
Behavior Disorders” to avoid incorrectly implying that all patients with ADHD are 
disruptive (Wender, 1995). In DSM-5 ADHD has been placed in the new chapter 
called “neurodevelopmental disorders”, reflecting the current conceptualization of the 
disorder (American Psychiatric Association, 2013).  
1.2 Prevalence and persistence of adult ADHD 
ADHD is currently one of the most prevalent disorders of child psychiatry with a 
world-wide prevalence rate estimate of about 5% (Polanczyk, de Lima, Horta, 
Biederman, & Rohde, 2007). About half of the children diagnosed with ADHD 
remain fully symptomatic in adulthood (Faraone et al., 2015), with an estimated 
persistence rate of 30-67% percent. Thus, it is an important disorder to be reckoned 
with also in adults, with an estimated prevalence of about 2-3% (Faraone, et al., 
2015). There is, however, some variance across nations. A recent survey, (Fayyad et 
al., 2017) found an overall prevalence of 2.8 % of DSM-IV defined adult ADHD 
across a range of nations, spanning from 1.4% in lower income countries to 3.6% in 
higher income countries. 
Although defined as a disorder with childhood onset, because contextual demands 
continue to increase in number, scope and complexity with age, coupled with 
decreased support systems, ADHD may often first be recognized and diagnosed in 
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adults (Turgay et al., 2012). Adult ADHD is associated with impaired functioning 
such as lower educational achievement, incarcerations/trouble with the law, 
unemployment, illicit drug use (Faraone, et al., 2015) and increased mortality 
(Dalsgaard, Ostergaard, Leckman, Mortensen, & Pedersen, 2015). Being a prevalent 
disorder with often debilitating outcomes, there is great need to obtain reliable and 
valid information to support the diagnosis of ADHD in adults based on both current 
symptoms and childhood symptoms.  
The most effective treatment for ADHD in children and adults according to existing 
research is stimulant drugs (Hinshaw & Scheffler, 2014). As these drugs are non-
specific, have side-effects and a potential for misuse, considerable controversy exist 
both in the popular press and academic literature concerning what ADHD is, and how 
it should be treated. Thus, a closer look into the diagnostic criteria of ADHD is 
warranted.  
1.3 Different diagnostic traditions 
Although both the DSM and ICD emphasize clinical utility, the scope of the clinical 
settings where the ICD is employed tends to be more varied and extensive than that 
of the DSM. The DSM is intended largely for use by highly trained mental health 
professionals. By contrast, the ICD is designed for health settings around the world, 
to be used not only by practitioners with widely divergent levels of expertise but also 
in cultural settings where assumptions about the etiology and the nature of disorders 
may be highly dissimilar from the Western milieu of the DSM. Accordingly, the ICD 
places stronger emphasis on public health applications than the DSM, and one 
reflection of this emphasis is the use of definitions that emphasize short text 
descriptions of each disorder rather than the polythetic symptom lists of the DSM (B. 
N. Cuthbert & Insel, 2013). A parallel tradition outside the DSM/ICD systems in 
diagnosing ADHD, still important and clinically relevant, is the Utah criteria 
(Wender, 1995). A description and comparison of the diagnostic criteria follows. 
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1.3.1 Diagnostic Criteria according to the DSM-IV and ICD-10 
The following description is adapted from the DSM 4th edition text revision 
(American Psychiatric Association, 2000). This is the version used to diagnose the 
adult ADHD patients in this thesis. The criteria have remained unchanged in the 
DSM-5, with the addition of more relevant examples of behaviors displayed by 
adults.  
Table 1. Diagnostic Criteria according to the DSM-IV 
A. Either (1) or (2): 
(1) Six (or more) of the following symptoms of inattention have persisted for at least 6 months to a degree 
that is maladaptive and inconsistent with developmental level: 
(a) Often fails to give close attention to details or makes careless mistakes in school-work, work, or other 
activities 
(b) Often has difficulty sustaining attention in tasks or play activities 
(c) Often does not seem to listen when spoken to directly 
(d) Often does not follow through on instructions and fails to finish schoolwork, chores, or duties in the 
workplace (not due to oppositional behaviour or failure to understand instructions) 
(e) Often has difficulty organizing tasks and activities 
(f) Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (such as 
schoolwork and homework) 
(g) Often loses things necessary for task or activities (e.g., toys, school assignment, pencils, books, or tools) 
(h) Is often easily distracted by extraneous stimuli 
(i) Is often forgetful in daily activities 
 
 (2) Six (or more) of the following symptoms of hyperactivity-impulsivity have persisted for at least 6 
months to a degree that is maladaptive and inconsistent with developmental level: 
Hyperactivity 
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(a) Often fidgets with hands or feet or squirms in seat 
(b) Often leaves seat in classroom or in other situation in which remaining seated is expected 
(c) Often runs about or climbs excessively in situations in which it is inappropriate (in adolescents or adults, 
may be limited to subjective feelings of restlessness) 
(d) Often has difficulty playing or engaging in leisure activities quietly 
(e) Is often “on the go” or often acts as if “driven by a motor” 
(f) Often talks excessively 
Impulsivity 
(g) Often blurts out answers before questions have been completed 
(h) Often has difficulty awaiting turn 
(i) Often interrupts or intrudes on others (e.g. butts into conversation or games) 
B. Some hyperactive-impulsive or inattentive symptoms that cause impairment were present before age 7 
years. 
C. Some impairment from the symptoms is present in two or more settings (e.g., at school [or work] and at 
home). 
D. There must be clear evidence of clinically significant impairment in social, academic, or occupational 
functioning. 
E. The symptoms do not occur exclusively during the course of a Pervasive Developmental Disorder, 
Schizophrenia, or Psychotic Disorder and are not better accounted for by another mental disorder (e.g., Mood 
Disorder, Anxiety Disorder, Dissociative Disorder, or a Personality Disorder) 
In the most recent version, the DSM-5, the definition of ADHD has been updated to 
include descriptions of symptoms more accurately associated with the adult version 
of the disorder. The age of onset criteria of 7 years has been changed to 12, due to 
research showing no clinical differences between children identified by 7 years 
versus those identified later with regard to treatment response, course and severity or 
outcome (American Psychiatric Association, 2013). Another change in the criteria is 
the lower number of symptoms required for adult diagnosis; while children must 
present with at least six symptoms from one or both subgroup dimensions, older 
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adolescents and adults (over age 17 years) must present with at least five symptoms. 
Diagnostic Criteria according to ICD-10 differs from DSM in requiring symptoms 
from all three domains of hyperactivity, inattention and impulsivity. In addition, ICD-
10 has an even stricter age of onset criterion of 5 years. Being originally published in 
1992 (WHO, 1992), it does not have updated adult symptom descriptions.  
1.3.2 Diagnostic Criteria according to the Utah Criteria  
The following description is adapted from the Appendix in Paul Wender’s 1995 book 
on adult ADHD (Wender, 1995). 
Table 2. Diagnostic Criteria according to the Utah Criteria 
I. Childhood Characteristics 
Childhood history consistent with ADHD in childhood. Obtaining reliable historical data usually requires 
input from the individual’s parents or older siblings. The following are [our – Wender and colleagues] 
diagnostic criteria for ADHD in childhood:  
A: Narrow Criteria (DSM-III) 
That the individual met DSM-III-R criteria (or DSM-IV when he wrote the book, probably DSM-5 now) for 
ADHD in childhood. 
B: Broad Criteria 
Both characteristics 1 and 2, and at least one characteristic from 3 through 6.  
1. Hyperactivity 
2. Attention deficits 
3. Behavioral problems in school 
4. Impulsivity 
5. Overexcitability 
6. Temper outbursts 
II. Adult characteristics 
A: The presence in adulthood of both characteristics 1 and 2, which the patient observes or says others observe 
in him, together with two of characteristics 3 through 7.  
1. Persistent motor hyperactivity 
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2. Attentional difficulties  
3. Affective lability 
4. Disorganization, inability to complete tasks 
5. Hot temper, explosive short-lived outbursts 
6. Emotional overreactivity 
7. Impulsivity 
B: Absence of the following disorders:  
1. Antisocial Personality Disorder 
2. Major Affective Disorder 
C: Absence of signs and symptoms of the following disorders:  
1. Schizophrenia 
2. Schizo-affective disorder 
D: Absence of Schizotypal or Borderline Personality Disorders or traits 
E: Associated features: Marital instability; academic and vocational success less than expected on the basis of 
intelligence and education; alcohol or drug abuse; atypical responses to psychoactive medications; family 
histories of ADHD in childhood, alcoholism, drug abuse, Antisocial Personality Disorder and Briquet’s 
syndrome. 
F: Child Temperament Questionnaire (Conners Abbreviated Rating Scale.) 
Although not necessary for diagnosis, a score of 12 or greater as rated by the patient’s mother is helpful for 
diagnostic purposes and may be predictive of treatment response. 
 
The Wender Utah criteria require a childhood history of ADHD including both 
inattentive and hyperactive symptoms, with one of the following additional 
symptoms: behavior problems in school, impulsivity, over-excitability or temper 
outbursts. Secondly, it requires an adult history of persistent attention problems and 
motor hyperactivity with at least two of the following symptom domains: affective 
lability, hot temper, stress intolerance, disorganization and impulsivity (Ward, 
Wender, & Reimherr, 1993). In other words, Ward and colleagues presented a quite 
strict definition of which symptoms should be present to qualify for an ADHD 
diagnosis. These criteria were originally presented as a list of 61 items in a 
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questionnaire, which was subsequently reduced to the 25 items that best distinguished 
an ADHD sample from control samples (i.e. healthy controls and depressed patients). 
Most of the final 25 items are thus actually not directly tapping into the core ADHD 
symptoms as described in the DSM or ICD, but were rather chosen for their 
discriminative ability in case-control samples. In sum, the Wender Utah criteria are 
more in line with the ICD criteria, and both are stricter than the DSM criteria. Despite 
these comprehensive diagnostic criteria, Wender proposed in his 1995 book that the 
adult prevalence of ADHD is between approximately 2 and 6-7 %. (Wender, 1995). 
1.4 Diagnostic challenges  
1.4.1 Heterogeneity 
Basing diagnoses of heterogeneous forms of psychopathology on rigid, highly 
specified lists of operationalized criteria means substituting a higher interrater 
reliability for the exclusion of a significant number of individuals, who by less 
stringent criteria would be counted as affected (Hyman, 2010). Problems created by 
strict overspecification are demonstrated by comparing diagnoses made with DSM-
IV and ICD-10 for disorders in which the intention was to detect the same patients. 
Although there are some disagreements between the DSM-IV and the ICD-10, many 
of the differences in operationalized criteria appear to be the accidental results of 
having two parallel processes of criterion writing (Hyman, 2010). Slade and Andrews 
(2001) used a single structured interview, the Composite International Diagnostic 
Interview, administered to a community sample of 10,641 people to derive DSM-IV 
and ICD-10 diagnoses. They found that minor alterations in wording resulted in the 
identification of different individuals as being affected. In a smaller sample enriched 
for prevalence of mental disorders, Andrews, Slade, and Peters (1999) found a 
concordance between DSM-IV and ICD-10 criteria of 83% for a depressive episode, 
but only 64% for obsessive-compulsive disorder, and as low as 35% for posttraumatic 
stress disorder. Thus the rigidly operationalized criteria of the DSM-IV and the ICD-
10 seem to exclude large numbers of plausibly affected individuals (indeed identified 
by the other system) who are likely in need of treatment (Hyman, 2010). In sum, 
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when you create rigid sets of narrow categories you create plenty of opportunities for 
diagnostic overlap. These overlaps are often referred to as comorbidities; the 
coexistence of two or more distinct psychiatric diagnoses (Maj, 2005). 
1.4.2 Practical implications of diagnostics and classifications  
It is widely recognized that ADHD both in children and particularly in adults, is more 
often than not accompanied by comorbid disorders (Singh, 2008; Sobanski, 2006). 
Thus, there is a need to investigate, research and further our knowledge into the 
various aspects that are associated with adult ADHD to illuminate its characteristics. 
As such, questions arise as how to differentiate between controls and ADHD patients 
(paper I), meaningful phenotypes within ADHD (such as aggressiveness in paper II), 
and comorbidities related to ADHD (such as insomnia in paper III). 
As is apparent from the diagnostic checklists presented above, psychiatric diagnoses 
are polythetic, not monothetic. Monothetic describes a category that shares the same 
identifying features across all its members, like birds, etc. Polythetic means that you 
have separate classes of symptoms, e.g. inattention and hyperactivity/impulsivity, 
where only a few (e.g. 5/6 of 9) of the symptoms need to be present from one class in 
order to qualify for a diagnosis, resulting in considerable heterogeneity. Several 
people can thus have non-overlapping symptomatologies and still qualify for the 
same categorical description. A further point is that psychiatric diagnoses in general 
are descriptive, consensus based entities meant to increase inter-rater reliability. They 
are not defined from biological understandings of the underlying etiologies, as this 
would have been premature, not to say impossible to determine, at least at the 
inception and inclusion of these categories in diagnostic manuals. Thus, the 
underlying etiological substrates leading to a diagnosis of e.g. ADHD may vary 
considerably between people defined within the same categorical diagnosis. The 
diagnostic heterogeniety is further complicated by the fact that there is no reliable 
litmus test for ADHD; a comprehensive clinical assessment based on the DSM 
criteria remains the gold standard for the diagnosis (Haavik, Halmoy, Lundervold, & 
Fasmer, 2010).  
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Extensive research shows that adults with ADHD appear to benefit from treatment 
with stimulant medications in similar ways as children (Kooij et al., 2012), including 
significant improvements on driving performance and other associated problems. 
Pharmacological treatment of ADHD, albeit found to be efficacious, involves 
regulated substances such as methylphenidate and amphetamines. Such drugs have a 
potential for abuse and misuse, e.g. as cognitive performance enhancers. Although 
fear surrounding the abuse of stimulants is an important issue, evidence suggests that 
children with ADHD who are treated with stimulant medication are less likely to 
develop a substance use disorder in adolescence and adulthood (Biederman, Wilens, 
Mick, Spencer, & Faraone, 1999). The benefits observed with ADHD treatment, 
however, emphasize the importance of recognition and treatment of adult ADHD 
(Kooij, et al., 2012). 
According to present diagnostic manuals, childhood symptoms of ADHD are 
particularly important to establish. Several other disorders that appear in adulthood 
may display symptoms similar to the core ADHD symptoms (e.g. affective disorders, 
substance use disorders and sleep disorders) (Sobanski, 2006). To add to the 
complexity, these disorders may often also be comorbid to ADHD (Halmoy et al., 
2010; Haavik, et al., 2010; Sobanski, 2006). The Wender Utah Rating Scale (WURS) 
was developed as a diagnostic aid to retrospectively evaluate the presence and 
severity of childhood symptoms of ADHD in adult patients (Ward, et al., 1993). It 
was developed independently from and partly in parallel with the diagnostic criteria 
of the DSM, but with some important differences between these sets of criteria as 
mentioned previously.  
In addition to establishing childhood presence of symptoms, questionnaires and 
symptoms checklists are often used to assess current symptoms of ADHD. The DSM 
criteria were based on concurrent childhood symptoms of ADHD, and have later been 
adapted to fit with behavioral characteristics of adults with ADHD. The Adult ADHD 
Self-Report Scale (ASRS) is one of the most commonly used instruments of current 
symptoms of ADHD in adults, and represents the official screening instrument of the 
World Health Organization (WHO) (Ronald C. Kessler et al., 2005). The ASRS 
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includes the 18 items representing current symptoms of ADHD according to the DSM 
and ICD, and has been extensively validated, albeit with an important caveat: most 
studies have used the short 6 item screener, not the full version with all 18 symptoms 
(e.g. (R. C. Kessler et al., 2007)) Thus, important information on the full ASRS 
screening properties is largely lacking from the research literature. 
1.4.3 Comorbidities and differential diagnostics 
A myriad of comorbid conditions such as impulse-control problems, personality 
disorders, anxiety, mood disorders, substance abuse, learning disorders and sleep 
disorders overlap with adult ADHD (Kooij, et al., 2012). Furthermore, a number of 
such conditions have symptoms that can directly mimic those of ADHD, including 
hyperactivity, impulsivity, inattention, and disruption of circadian rhythm, adding to 
the complexity of recognition and diagnosis of ADHD in adults. Accordingly, 
disorders frequently comorbid to adult ADHD span several diagnostic 
bounds/categories, and create serious impairments on their own. Thus it is obvious 
that there can be uncertainties when assessing patients, untangling all of these 
different strands of clinically important information and potential treatment targets. 
Even though researchers such as Kooij, et al. (2012) list extensive comorbidities, two 
vital problem domains conspicuously lacking from their review are insomnia (only 
sleep-onset insomnia is briefly mentioned) and aggressiveness. 
Comorbidities and symptom overlap between disorders may imply that there is a 
problem with the classification system, rather than any meaningful association 
between underlying diseases indexed by that classification. The fact that we are not 
dealing with clearly validated disease entities does not, however, mean that there is 
no point studying psychiatric comorbidity. Indeed, the opposite is the case, since 
understanding the presence of comorbidity between psychiatric conditions offers a 
means of correcting and validating psychiatric nosology. The study of comorbidity 
does not depend upon the existence of well-validated disease entities, but may 
actually be particularly informative in the case of poorly validated disorders (Angold, 
Costello, & Erkanli, 1999). Even if many, or even all, examples of comorbidity turn 
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out to be alternative expressions of some unitary underlying psychopathological 
process or processes, the phenomenon currently called “comorbidity” will still need 
to be explained (Angold, et al., 1999). However, there is no reason to suppose that 
comorbidities will go away (Angold, et al., 1999). “Diseases” are not obvious 
“natural” categories in any branch of medicine. Boundary problems are abound in 
relation to all medical disease, just as they are in mental disorders (Angold, et al., 
1999). All normally distributed phenomena struggle with boundary issues, where 
clear cut-offs are illusive and non-existing.  
A problem with not recognizing ADHD, CD, ODD and Learning Disorders as 
separate disorders is that the etiology, epidemiology, biological substrates and natural 
history or response to treatment is left unknown for ”pure” instances of these 
disorders, if they are only studied when lumped together (Wender, 1995). However, 
the reverse is more common and can also be quite problematic. If a research design is 
contingent upon identifying and characterizing only patients with  ”pure” phenotypes 
of an arbitrarily defined categorical diagnosis, the naturally occurring overlaps 
between the diagnosis in question and other diagnoses may be neglected, overlooked, 
underappreciated and understudied. This is particularly problematic when a bulk of 
research shows that a categorical diagnosis in psychiatry usually does not come alone 
(Angold, et al., 1999). 
This recognition has been co-existing alongside the categorical diagnostic systems for 
quite a while, especially in child- and adolescent psychiatry. To address this problem, 
Gillberg for example has introduced the concept of ESSENCE (Gillberg, 2010). 
ESSENCE stands for Early Symptomatic Syndromes Eliciting Neurodevelopmental 
Clinical Examinations. This alerts the clinician to meaningful symptoms spanning 
several psychiatric/pediatric categories that should elicit clinical attention and care to 
ensure an optimal developmental trajectory. To split syndromes into more precise 
diagnoses in a state-of-the-art way will only be possible if there is anything 
meaningful to start splitting from. In this sense a relevant group of cases “lumped” 
together. Gillberg stresses that the introduction of a new term such as ESSENCE 
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should not be taken as support for lumping rather than splitting, but for the order in 
which those two aspects of diagnosis is approached (Gillberg, 2010). 
It would not be surprising if some aspects of comorbidity do arise because our 
diagnostic criteria have not drawn the appropriate boundaries between disorders. That 
is one reason for doing research on comorbidity. Both categorical and quantitative 
models offer complementary approaches to the issue of nosology (Angold, et al., 
1999). Overall, work in this area can be seen as having treated the diagnostic criteria 
as “hypotheses” to be examined and tested. In our present state of knowledge this 
would appear to be the right attitude to bring to psychiatric diagnoses (Angold, et al., 
1999).  
Insomnia and aggressiveness frequently co-occur with a diagnosis of ADHD, but are 
not part of the official diagnostic criteria. They are, however, in focus in the present 
thesis, and will be shortly described in the following paragraphs. 
1.5 Insomnia 
Sleep disturbance is increasingly recognized as an important, but understudied, 
mechanism in the complex and multi-factorial causation of the symptoms and 
functional disability associated with psychiatric disorders (A. G. Harvey, Murray, 
Chandler, & Soehner, 2011). People with ADHD typically struggle with maintaining 
structure and regulating their behavior and daytime activities. The regulatory 
difficulties also seem to affect the diurnal rhythm, as ADHD has been associated with 
various sleep problems, with insomnia being one of the most commonly reported 
comorbid sleep conditions (Instanes, Klungsoyr, Halmoy, Fasmer, & Haavik, 2016). 
Insomnia is defined as difficulties initiating or maintaining sleep, early morning 
awakenings or having non-restorative sleep, lasting for at least a month (American 
Psychiatric Association, 2000). Insomnia is one of the most frequent health concerns 
in the general population as well (Buysse, 2013), typically affecting 6% to 15% of the 
adult population (Pallesen, Sivertsen, Nordhus, & Bjorvatn, 2014). Insomnia causes 
irritability and fatigue as well as reduced productivity, increased absenteeism, 
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increased morbidity, and increased health care costs (Buysse, 2013). Most studies 
examining the relationship between insomnia and ADHD have been performed in 
children and adolescents, and the few studies addressing insomnia in adult ADHD 
have given conflicting results (Cohen-Zion & Ancoli-Israel, 2004; Owens, 2005). 
One study found that more than half of adults with probable ADHD fulfilled the 
criteria for insomnia (Voinescu, Szentagotai, & David, 2012). In another study, four 
of five adults with ADHD reported having sleep problems, irrespective of sex and 
subtype (Fisher et al., 2014), indicating the importance of addressing insomnia in 
adult ADHD.  
1.6  Aggressiveness 
Aggressiveness can be defined as any behavior directed toward an individual with the 
immediate intent to cause harm (Anderson & Bushman, 2002). Aggression plays an 
important role in evolution, both in defense and predation and is part of the normal 
behavioral repertoire of most, if not all, species. However, when exhibited in humans 
in the wrong context, aggression can lead to social maladjustment and crime. Clearly, 
aggression has a high cost to individuals and to society, yet there remains 
considerable uncertainty about the best ways to manage aggressive behavior 
(Asherson & Cormand, 2016). As both low and high levels of aggression can be 
detrimental to survival and reproduction, it has been hypothesized that aggression is 
under stabilizing selection, which implies that variation in aggression will show 
significant heritability (Asherson & Cormand, 2016). 
Aggressiveness can be a serious problem, both at a societal level and individual level, 
causing significant (social) impairment for patients and distress for their 
surroundings. Violence, which is strongly related to aggressiveness, is the sixth 
leading cause of burden of disease for people aged 15–44 years worldwide (WHO, 
2008). To date, most interventions designed to reduce violence risk typically have 
small effects, reflecting our limited understanding of its causes and stressing the need 
for further studies (McGuire, 2008; Terrie E. Moffitt, 2005).  
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As a complex phenomenon, aggressiveness spans across numerous facets of human 
behavior, ranging from emotional lability and temperamental traits (e.g., hot-
tempered, short fuse, irritable) to physical violence (Lesch, Araragi, Waider, van den 
Hove, & Gutknecht, 2012). These traits are frequently found among youth with 
ADHD. Youth with ADHD often have co-existing disorders, some of which are 
closely related to aggressiveness and violence, such as conduct disorder (CD) and/or 
oppositional defiant disorder (ODD) and disorders characterized by symptoms 
defined within the broader term of antisocial behavior (Dalsgaard, Mortensen, 
Frydenberg, & Thomsen, 2002). These disorders put youth with ADHD at high risk 
of problems associated with aggressiveness in adulthood (Klassen, Katzman, & 
Chokka, 2010), especially when the aggressive behavior has an early onset 
(Hofvander, Ossowski, Lundstrom, & Anckarsater, 2009). This can be illustrated by 
the fact that around 30% of youth and 25% of adult prison inmates are found to 
qualify for an ADHD diagnosis (Young, Moss, Sedgwick, Fridman, & Hodgkins, 
2014). Studies of childhood aggressiveness in adults can, therefore, be of great 
importance to improve our understanding of adult ADHD.  
1.7 Genetics of aggressiveness in ADHD 
The high heritability of neuropsychiatric disorders (46.3% as a class) (Polderman et 
al., 2015) is an enticing clue that genetics may provide a neurobiological framework 
for comprehending conditions that have eluded biological understanding for decades. 
Heritability refers to the proportion of phenotypic variance due to genetic factors 
(Gandal, Leppa, Won, Parikshak, & Geschwind, 2016). Heritability estimates 
indicate that inherited genetic variants contribute substantially to disease liability, 
often more so than early environmental influences or non-inherited, de novo 
mutations. However, clearly gene and environment usually contribute together 
(Gandal, et al., 2016). In facts, studies have found ADHD to have a particularily high 
heritability, estimated to be up to 88% across the lifespan (Franke et al., 2012; 
Larsson, Chang, D'Onofrio, & Lichtenstein, 2013). 
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The genetic and environmental contributions to the variation and longitudinal 
stability in childhood aggressive behavior has been assessed in two large twin 
cohorts; the Netherlands Twin Register (NTR), and the Twins Early Development 
Study (TEDS; United Kingdom) (Porsch et al., 2016). These studies find between 50-
80% heritability of aggressive behavioral problems, and based on these longitudinal 
samples the authors conclude that childhood aggression is a stable trait. Further, they 
report that individual differences at various ages are mainly due to genetic differences 
between individuals. Additionally, genetic influences are also found to be the major 
source of stability in aggressive behavior throughout childhood. Based on the large 
sample size, the authors furthermore conclude that shared environmental influences 
are significant, especially for boys (Porsch, et al., 2016). 
Much of the genomic DNA sequence differences between any two people are 
common (frequency >5%) single nucleotide polymorphisms (SNPs). A genome-wide 
association study (GWAS) is a hypothesis-free test to identify genetic variants 
involved in disease risk. GWAS typically targets millions of SNPs, common variants 
of small effect (Akutagava-Martins, Rohde, & Hutz, 2016). GWAS does not identify 
a gene per se, but a region that is associated with disease status. Because of localized 
patterns of correlation (linkage disequilibrium), a sample of 250,000 to 500,000 of 
these SNPs can test the hypothesis that one or more common variants explain part of 
the genetic risk for a disease (Cichon et al., 2009). When genome-wide significance is 
achieved (often defined as P < 5 × 10−8), the effective confidence interval 
surrounding a ‘lead’ or ‘index’ SNP (with the lowest P-value in a given locus) is set 
by the surrounding region of linkage disequilibrium, which spans on average ~40 kb, 
but is highly variable throughout the genome. Identifying the underlying ‘causal’ 
variant(s) within a target region, and its biological effect, is typically an enormous 
challenge (Gandal, et al., 2016). A majority of common disease-associated genetic 
variation lies outside coding regions and is enriched in regulatory elements such as 
enhancers or promoters. Variants in these regulatory elements act to modulate the 
expression and splicing of distal gene targets, potentially with large effect (Gandal, et 
al., 2016). Although no single polymorphism reached genome-wide significance in a 
study of Norwegian cases and controls (Zayats et al., 2015), recent meta-analyses 
 32 
using larger samples sizes from multiple populations have shown many genome wide 
significant findings (Demontis et al., 2017). 
Given that ADHD and aggression often co-occur and that both traits are highly 
heritable, twin studies have noted the possibility of shared genetic etiology between 
ADHD and aggression. A common genetic factor has been reported among ADHD 
and symptoms of aggression in 9–10-year-old children (Tuvblad, Zheng, Raine, & 
Baker, 2009). Likewise, it has been suggested that impulsivity and aggression are 
genetically mediated to a similar extent (Seroczynski, Bergeman, & Coccaro, 1999).  
The estimates and expressions of aggressiveness are influenced by the age of the 
study participants. The literature reports stability of aggressiveness between 
childhood and adulthood, with adolescence as a transient period with little stability in 
this trait (Terrie E. Moffitt, 2005). Genes seem to explain little variation in adolescent 
aggression, but are likely to account for individual differences in childhood and adult 
aggression (Lyons et al., 1995). Also, given higher levels of aggression in males and 
higher genetic load in males with antisocial behavior compared to females, it is an 
open question whether genetic propensity is of greater importance in one sex over the 
other (Miles & Carey, 1997; Tuvblad & Baker, 2011). Interestingly, similar 
considerations of age and sex effects are also present in studies of ADHD as well as 
when ADHD is co-morbid with aggressive behavior (Faraone, et al., 2015; Faraone, 
Biederman, Keenan, & Tsuang, 1991). As aggressiveness and ADHD are highly 
linked, aggressiveness may turn out to be an ADHD endophenotype. An 
endophenotype may be defined as an intermediary between a biological substrate and 
a disorder, one that lies in the gap between gene and disease process, so that by 
examining their genetic basis we would understand something about the biology of a 
psychiatric disease (Flint & MunafÒ, 2007). Endophenotypes may be divided into 
two different classes: those that simply share genetic factors with the phenotype thus 
being indicative of pleiotropic effects or, more importantly, those that act as 
mediating factors. In the latter case, the causal pathways from genetic variants to 
phenotype necessarily pass through the endophenotype (Akutagava-Martins, et al., 
2016). An endophenotype may be not exclusive for a disorder, but may be associated 
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with a range of genetically related pathologies. An important caveat to mention is that 
several different aggression measures have been utilized to assess the genetic and 
environmental influences on its development (Veroude et al., 2015), reflecting that 
there is no consensus regarding its definition (Ramirez & Andreu, 2006). 
1.8 Aims of the present thesis 
The overall aim of the thesis was to investigate symptom domains in adults with 
ADHD including and beyond the ones described in the Diagnostic and Statistical 
Manual of Mental Disorders (DSM).  
Paper I) investigated the psychometric properties and the clinical utility of self-
reported childhood symptoms (WURS) versus current symptoms (ASRS) using two 
frequently used symptom checklists for adult ADHD. 
Paper II) investigated the prevalence and clinical correlates of insomnia in adult 
ADHD. Using a case-control sample, we studied the importance of insomnia and the 
effects of symptoms of ADHD on its prevalence in both an adult ADHD sample and 
in random population controls. 
Paper III) investigated the genetic components of aggressiveness in ADHD. Using a 
GWA design with international samples of youth and adults with ADHD, we 
investigated the genetic substrate of childhood aggressiveness in adult ADHD.  
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2. MATERIALS AND METHODS 
2.1 Participants 
This thesis is mainly based on a case-control sample of a nation wide sample of 
adults with ADHD and a population based control sample. Paper III represents an 
international collaboration adding European samples of both youth and adults with 
ADHD.  
2.1.1 Patients 
The aim of the collection of the main adult ADHD sample was to gather a naturalistic 
sample as encountered in general clinical practice. The prescription of central 
stimulants for adults was legally restricted in Norway until 1997. From October 1997 
until May 2005, adults (≥18 years) with ADHD (or Hyperkinetic Disorder according 
to the ICD system which is the official diagnostic manual in use in Norway) were 
allowed to receive central stimulants only after a systematic and mandatory 
diagnostic evaluation by one of three regional diagnostic committees, i.e. the Expert 
Committees for Hyperkinetic Disorder/ADHD. Patients were referred to the 
committees by their psychiatrists, general practitioners or hospital doctors. Each of 
the diagnostic committees consisted of three to five clinicians (mainly psychiatrists 
and neuropsychologists), with special experience on diagnosing ADHD in children 
and adults. A few pioneering clinicians at that point also diagnosed and treated adult 
patients with ADHD in addition to the committees, by special permissions. The data 
obtained by the Expert Committees of Hyperkinetic Disorder/ADHD were not 
primarily designed as a patient registry, but due to the compulsory referral system for 
adults considered for central stimulant treatment for ADHD, it became a national 
cohort of adult ADHD patients. During almost eight years, the committees handled 
more than 5000 patient referrals, and nearly 70% were recommended for treatment (n 
= 3397). In May 2005, National Guidelines for Diagnosing Lifespan ADHD were 
implemented by the Norwegian Health Authorities. Since then the diagnosis and 
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treatment of adult ADHD was handled by individual specialists in psychiatry and 
clinical psychology without the direct involvement of the former expert committees. 
Diagnostic assessment 
The referral procedure to the expert committees required both thorough descriptions 
of the patient’s current symptoms and functioning and informant information about 
childhood behavior and functioning. Results from physical and psychiatric 
examinations were also required. The expert committees then reviewed the patient’s 
records to confirm, or disprove, the diagnosis of ADHD. A formal conclusion was 
made recommending or not recommending treatment with central stimulants, based 
on a confirmed diagnosis and the absence of contra-indications for such treatment 
(mainly psychosis or ongoing substance abuse). The diagnostic assessment was done 
according to the ICD-10 research criteria for Hyperkinetic Disorder, with two 
modifications; allowing the inattentive subtype as sufficient for the diagnosis and 
allowing for the presence of comorbid psychiatric disorders as long as the criteria for 
ADHD were fulfilled and present before the appearance of the comorbid disorder. 
This diagnostic assessment strategy was chosen as a compromise between the fact 
that the ICD-10 was the official diagnostic system used in Norway, and the need to 
have an assessment comparable with the international DSM-IV standards. 
Recruitment to the Norwegian adult ADHD patient sample in this thesis was based on 
the address lists from the Expert Committees. Patients all across Norway were invited 
directly by posted mail to join the project. A total of 1700 invitations were sent to 
patients (mainly diagnosed after the year 2000) from 2005 to 2007. By December 
2007, 338 (19.9%) of the invited patients had returned completed questionnaires and 
were included in the study. Subsequently, clinicians (general practitioners, 
psychiatrists and clinical psychologists) from all over Norway were also invited to 
recruit patients with a verified diagnosis of adult ADHD. The inclusion criteria for 
these subsequently recruited patients were 1) a diagnosis of ADHD/Hyperkinetic 
Disorder received in adulthood confirmed by a clinician outside the project according 
to DSM-IV or ICD-10 criteria, and 2) age ≥18 years at the time of inclusion. There 
were no formal exclusion criteria.  
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2.1.2 Controls 
The control sample included individuals randomly recruited from the general 
population in Norway having the same age range as the Norwegian adult ADHD 
patients. For this purpose, the Medical Birth Registry of Norway (MBRN) was used. 
The MBRN is based on compulsory notification of all births in Norway from 1967. 
During January and March 2007, 2163 invitation letters were sent out to a randomly 
selected sample of the Norwegian population between 18 and 40 years old, based on 
the MBRN. By December 2007, 417 of these (19.3%) had responded with completed 
questionnaires and were included in the study. Since 2008, patients and controls 
received reminders by mail or telephone, resulting in gradually increasing response 
rates. Nearly 300 patients and controls also returned symptoms score questionnaires 
at multiple time points (data not included in this thesis). 
2.2 Assessment 
All participants included in paper I and II filled in questionnaires for past and current 
ADHD symptoms, symptoms of comorbid lifetime disorders and problems, as well as 
sociodemographic data including educational and occupational activity. A sample of 
blood or saliva was collected for genetic analysis, used in paper III. The following 
symptom checklists were used in the papers:  
2.2.1 WURS – Wender Utah Rating Scale (Paper I and III) 
The WURS is a 25-item questionnaire used for retrospective assessment of childhood 
symptoms of ADHD in adults (Ward, et al., 1993). For each item, the participant was 
asked to evaluate if she/he as a child was (or had) a specific symptom and to rate it 
according to the following four response categories: “not at all/very slightly” (0), 
“mildly” (1), “moderately” (2), quite a bit” (3), or “very much” (4). The arithmetic 
sum of the responses yields a total range from 0 to 100. Internal consistency for the 
WURS measured by Cronbach’s alpha was .967. A principal component analysis 
(PCA) was run to to determine its factor structure, producing three factors: 1) 
Aggressiveness and Social Problems, 2) Learning and Attention Problems, and 3) 
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Dysthymia. The adult measure of childhood aggressiveness in the aADHD samples 
was derived from the highest loading items on the first factor the WURS.  
2.2.2 ASRS – Adult ADHD Self Report Scale (Paper I and II) 
The Adult ADHD Self-Rating Scale (ASRS) is the World Health Organization’s 
(WHO) official screener for ADHD, and consists of the 18 symptoms listed in the 
DSM-IV criteria A (Ronald C. Kessler, et al., 2005). Nine items assess symptoms of 
inattention (ASRS-IA) and nine items assess hyperactive/impulsive symptoms 
(ASRS-HI), respectively, rated on a scale from 0 to 4 (0 = never, 1 = rarely, 2 = 
sometimes, 3 = often and 4 = very often), yielding a total range of 0–72. The total 
scores on the two subscales of IA and HI were used as continuous measures of the 
two main symptom domains of ADHD. Cronbach’s alpha was 0.92 on the ASRS- IA 
subscale and 0.92 on the ASRS-HI subscale.  
The ASRS version used in this study corresponds to the one used by the Expert 
Committees of Hyperkinetic Disorder/ADHD. It was originally translated and re-
translated (by an English-native employee of the Norwegian Department of Health 
and Social Welfare) and has later been evaluated by four experienced psychiatrists 
from the adult ADHD project group.  
2.2.3 BIS – Bergen Insomnia Scale (Paper II) 
The Bergen Insomnia Scale (Pallesen et al., 2008) was constructed based on the 
diagnostic criteria for insomnia according to the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV) (1). It includes six items rated on an 8-point scale, 
ranging from 0 to 7 days per week during the last month. The first four assess sleep 
impairment (criteria A of the DSM-IV) (has it taken you more than 30 min to fall 
asleep after the light was switched off; have you been awake for more than 30 min 
between periods of sleep; have you awakened more than 30 min earlier than you 
wished without managing to fall asleep again; have you felt that you have not had 
enough rest after waking up). The last two items refer to daytime sleepiness/tiredness 
that has affected your participation at school or work, and your dissatisfaction with 
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sleep respectively (criteria B). The criteria for a DSM-IV diagnosis of insomnia are 
fulfilled if a respondent reports ≥3 days per week on at least one of the A-items and 
≥3 days per week on at least one B item. In addition, a total composite score is 
calculated by adding together the scores for each item, with a possible range of 0–42. 
The BIS thus provides both a dichotomous score for the presence of insomnia and a 
dimensional symptom score. The Cronbach’s alpha of the BIS scale used in the 
present study was 0.86.  
In addition, the patients answered 31 questions concerning sociodemographic factors 
including educational and occupational level, past and present medical treatment and 
lifetime history of comorbid disorders. They were also asked about the presence of 
ADHD and comorbid/other disorders in first degree family members. All patients 
were asked to give a form to their doctor (mainly psychiatrists) with questions 
regarding diagnosis and medical treatment. These questionnaires were specifically 
designed for the adult ADHD project.  
2.3 Statistics 
A Principal Component Analysis (PCA) was run to determine the latent structure of 
the WURS. The PCA was run with Varimax rotation and yielded three factors with 
Eigen values above one. This factor structure was generated as part of paper I. The 
aggressiveness factor in paper III was derived from the factor explaining the greatest 
amount of variance in responses to the WURS (30.7%). The highest loading items 
(0.74–0.82) in this factor all represented prototypical elements of aggressiveness ( 
“temper outburst/tantrums,” “angry,” “hot- or short-tempered/low boiling point,” 
“disobedient with parents/ rebellious/sassy,” “losing control of myself,” and 
“irritable”).  
In paper I, the following calculations were included: Sensitivity = ∑ True positive / ∑ 
Disorder, Specificity = ∑ True negative / ∑ No disorder, Positive Likelihood Ratio = 
Sensitivity / (1 – Specificity), Negative Likelihood Ratio = (1 – Sensitivity) / 
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Specificity, Diagnostic Odds Ratio = Positive Likelihood Ratio / Negative Likelihood 
Ratio. 
Table 3. Screening properties 
 Disorder decided by “Gold Standard” 
 
 
Test result  
 
 Disorder No disorder Total 




T (Test positive) 




T (Test negative) 
 T (Disorder) T (No disorder) (Grand) Total 
 
In paper I we used Receiver Operating Characteristics Area Under the Curve (AUC), 
Diagnostic Odds Ratio (DOR) and Likelihood Ratio (LH) to obtain statistics that 
were unaffected by prevalence in our study sample (rather than e.g. Positive 
predictive value, which is biased by the sample prevalence of the disorder). 
2.3.1 Genome-wide association (GWA) of aggressiveness (paper 
III) 
In the aADHD sample, single nucleotide polymorphisms (SNPs) were tested for 
association with the WURS-derived measure of aggressiveness in the form of linear 
regression carried out using post-imputation dosage data (Purcell et al., 2007). 
Regression models were adjusted for age and sex. Genotype data of each site were 
first processed individually. The results were then combined with the use of fixed-
effects inverse variance meta-analysis (Willer, Li, & Abecasis, 2010). Only SNPs 
with minor allele frequency (MAF) equal to or above 1% and imputation INFO 
measure equal to or above 0.6 were included in the analyses. Genomic control, QQ 
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plotting, and regional plotting of top loci were applied to check the integrity of test 
statistics (Cuellar-Partida, Renteria, & MacGregor, 2015; Devlin & Roeder, 1999). 
The genomic inflation factor was calculated (Willer, et al., 2010). A genome-wide 
significance threshold of 5.00E-08 was adopted to correct for multiple testing. 
GWA analyses of irritable and defiant/vindictive dimensions of ODD in cADHD 
sample was performed in PLINK software in the form of linear regression adjusted 
for sex and age (Purcell, et al., 2007). Details of the analyses are described elsewhere 
(Aebi et al., 2016).  
2.4 Ethics 
All participants filled in and signed a written informed consent form. The Adult 
ADHD project was approved by the Regional Committee for Medical Research 
Ethics of Western Norway IRB # 3 (FWA 00009490, IRB 00001872) and the 
Norwegian Data Inspectorate. The participants received NOK 250 for returning blood 
or saliva samples and questionnaires. All international samples were also ethically 




3. RESULTS  
3.1 Paper I 
In Paper I we found that both the WURS and the ASRS had excellent discriminatory 
values, with an AUC of .956 (95% CI: .946 - .965) for the WURS, and .904 (95% CI: 
.888 - .921) for the ASRS. The optimal cut-off balancing the trade-off between 
sensitivity and specificity for the respective scales may vary depending on the aims in 
the specific clinical or research setting. The results showed a three-factor structure of 
the WURS in line with previous research (Caci, Bouchez, & Baylé, 2010; McCann, 
Scheele, Ward, & Roy-Byrne, 2000; Stanton & Watson, 2016), with details differing 
somewhat at item level. We named the three WURS factors Aggressiveness and 
Social Problems, Learning and Attention Problems and Dysthymia, respectively. The 
ASRS had as expected a two-factor structure, with inattentive symptoms in the first 
factor and impulsivity items having the highest loadings on the second 
hyperactivity/impulsivity factor. The internal consistencies of the two instruments 
were high. Our findings fit well with previous cut-off suggestions by Ward, et al. 
(1993) for the WURS and Kessler, et al. (2005) on the full 18 item ASRS (table 3).  
Contrary to the critique raised against the WURS for lacking content validity (i.e. 
diverging from the DSM symptom criteria) (Stanton & Watson, 2016), we found that 
it had a very high criterion validity (i.e. being highly predictive of an ADHD 
diagnosis). Furthermore, we found that the very items driving this discriminatory 
ability were part of the Learning and Attention problems factor of the WURS. The 
items represent developmentally important behaviors well recognized as core ADHD 
symptoms (WURS 1: Concentration problems, Easily distracted and WURS 7: 




3.2 Paper II 
In Paper II we used the Bergen Insomnia Scale (BIS) to measure insomnia and the 
Adult ADHD Self-Report Scale (ASRS) to assess ADHD symptom domains. We 
found that insomnia was far more frequent among adults with ADHD (66.8%) than in 
the population controls (28.8%) (P < 0.001). Insomnia was more common in adults 
with the combined subtype of ADHD than in those with the inattentive subtype 
(79.7% and 55.6%, respectively) (P = 0.003). For self-reported current ADHD 
symptoms, inattention was strongly correlated to insomnia. Patients currently using 
stimulant treatment for ADHD reported a lower total insomnia score compared to 
patients without medication (P < 0.05). Regression analyses showed that the self-
reported IA subscale of the ASRS significantly contributed to explain an insomnia 
diagnosis in the ADHD and the control group, while both the ASRS-HI and ASRS-IA 
subscales contributed significantly when the total BIS score was used as an outcome 
variable. Our findings support previous findings indicating that the severity of sleep 
problems are positively related to the severity of ADHD symptoms (Schredl, Alm, & 
Sobanski, 2007). The finding that inattentive symptoms had a higher correlated with 
insomnia symptoms among the controls than in the ADHD patients, suggests that a 
close association between inattentive symptoms and insomnia is not restricted to 
adults with an ADHD diagnosis. However, without any evidence of a directional 
relationship, inattentive symptoms may as likely be a consequence of sleep problems 
as the other way around. 
3.3 Paper III 
In Paper III we conducted a Genome Wide Association (GWA) study of a childhood 
aggressiveness phenotype in an adult ADHD sample, and compared this with GWA 
signals of dimensions of oppositionality (defiant/vindictive and irritable dimensions) 
in an adolescent sample. In total, 1,060 adult patients as well as 750 children and 
adolescents with ADHD were available for the analyses. The age ranges in the 
aADHD samples were 17–75 in the German sample, 18–57 in the Norwegian sample, 
and 17–60 in the Spanish sample. In the cADHD sample, the age range was 5–17. 
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GWA analyses revealed no genome-wide significant hits in either the aADHD 
sample nor in the cADHD sample, as no single polymorphism reached genome-wide 
significance (P<5.00E-08). No hits remained significant among protein-coding genes 
investigated after correcting for multiple comparisons. We did however identify a 
number of biologically interesting markers using less stringent significance levels.  
The  strongest signal was noted for rs10826548 within a long non-protein coding 
RNA gene. Such non-protein coding RNAs play a critical role in regulation of gene 
expression, and have been associated with neuropsychiatric disorders, including 
ADHD.  The second most significant loci was identified as rs35974940 in the 
neurotrimin gene. This is a protein-coding gene, predominantly expressed in the 
central nervous system. Taken together, the study identified biological markers 







4.1 Main findings 
The studies show that ADHD patients suffer extensively, both from recognized core 
symptoms in the DSM, and from symptom domains often labeled as comorbidities. 
We found that the WURS with its broader range of symptoms identified adult ADHD 
patients even better than the DSM derived ASRS. Insomnia was found to be a 
common problem in the adult ADHD sample, with two out of three patients 
qualifying for a diagnosis based on the BIS. Albeit we did not find statistically 
significant GWAS hits, aggressiveness may be a promising endophenotype in what 
we today consider the ADHD landscape. Taken together, the results in the present 
thesis suggest that we need to broaden our approach and scope when investigating 
and treating patients with ADHD. We need to go beyond the classic symptom 
domains of inattention, hyperactivity and impulsivity, and recognize that patients 
qualifying for an ADHD diagnosis also have other, important impairing symptom 
domains. These domains, such as aggressiveness, insomnia and learning problems, 
need to be addressed in order to successfully help the adult ADHD patient.  
The use of the word “diagnosis” in psychiatry carries an implicit and misleading 
connotation that stems from the use of the word in other areas of medicine, where 
diagnostic tests and diagnostic signs and symptoms are validated against an 
independent criterion for determining the presence or absence of the disorder 
(Wender, 1995). In the absence of well-validated and universally accepted diagnostic 
criteria, there is a risk for both overdiagnosis and underdiagnosis. This problem is 
characteristic for broader parts of medicine, not purely in the context of ADHD. 
However, this is of particular significance in a disorder for which controlled stimulant 
substances with potential for abuse are first-line treatments (McGough & Barkley, 
2004). Thus, paper I is important in that it addresses the psychometric properties of 
two different screening instruments used in parallel on a well validated sample of 
clinically ascertained adult ADHD patients and a matched/randomly selected 
population control sample. Our findings add to the discussion as to what the defining 
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features of adult ADHD really are, and regardless of ongoing controversy point to the 
fact that clinical management of this patient group requires a broader focus than the 
narrow DSM criteria for ADHD alone. 
4.2 Is there such a thing as ADHD?  
ADHD is the name of a syndrome, but applying the same name to problems suffered 
by a group of individuals does not necessarily mean that “they have the same thing”. 
With the inherent lack of independent criteria and biological substrates, it could be 
helpful if we expended less effort on trying to select the exact signs and symptoms 
that characterize the illness. There is no “pure” ADHD and further phenomenological 
redefining of symptoms chosen “to make” the diagnosis is not based on independent 
characteristics at a different level of discourse, meaning that the diagnosis as it is now 
is based upon clinical descriptions, not etiological considerations or a 
pathophysiological foundation (Wender, 1995).  
Although issues such as lacking objective criteria for an ADHD diagnosis, as well as 
the problems regarding comorbidities, it is important to distinguish between validity 
and utility in considering psychiatric diagnoses. Diagnostic categories defined by 
their symptoms should be regarded as valid only if they have been shown to be 
discrete entities with natural boundaries that separate them from other disorders. 
Although most diagnostic concepts have not been shown to be valid in this sense, 
many possess high utility by virtue of the information about outcome, treatment 
response, and etiology that they convey. They are therefore helpful working concepts 
for clinicians (Kendell & Jablensky, 2003). 
ADHD may be more an indication of a general psychopathology factor (Caspi et al., 
2014; Kotov et al., 2017), an emerging view that may prove to be more harmonious 
than the traditional categorical entities proposed by diagnostic systems such as the 
DSM and ICD. In fact, recent genetic findings from genome wide association studies 
illustrate that most genetic liability to psychiatric disorders are shared across 
categorical boundaries (Cross-Disorder Group of the Psychiatric Genomics, 2013; 
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Cross-Disorder Group of the Psychiatric Genomics et al., 2013). One of the most 
consistent findings in recent psychiatric research is that of shared genetic liability, 
with several common factors identified across disorders. What remain to be 
determined are the specific factors that result in a given phenotype rather than another 
(Akutagava-Martins, et al., 2016). Although ADHD has been a focus of attention for 
clinicians for centuries with changing symptom descriptions, an issue that seems to 
remain constant is the dysregulation seen across several brain-based behavioral 
domains such as attention, impulsivity and activity.  
Like most psychiatric conditions, ADHD originates from important genetic 
vulnerabilities and other forces. It’s a far different world from half a century ago, 
when environmental and cultural theories were in ascendancy. But the undeniable 
role of biology cannot blind us to the fact that genetic tendencies unfold through 
interactions with a host of micro (families; schools) and macro (policy; health care) 
processes. Viewing ADHD as entirely biological is as misleading as it is to claim that 
ADHD is simply a social construction or the result of overly lax parenting (Hinshaw 
& Scheffler, 2014). Interestingly, a ”low ADHD trait” has not been found to be 
significantly heritable, but rather very malleable depending on environmental factors 
(Greven et al., 2016). 
4.3 Categories vs. Dimensions 
The ideal of medicine is to find ever more specific biomarkers and narrow categories 
in the pursuit of optimizing diagnosis and treatment. However, longitudinal studies 
looking at discretely defined psychiatric disorders together have found these to be 
better explained with one higher order general psychopathology dimension. This 
dimension has been labeled “the p factor” as it is conceptually parallel to a familiar 
dimension in psychological science: the g factor of general intelligence (Caspi, et al., 
2014). Higher p scores are associated with more life impairment, greater familiality, 
worse developmental histories, and compromised early-life brain function. The p 
factor explains why it is challenging to find causes, consequences, biomarkers, and 
treatments with specificity to individual mental disorders (Franke, 2016). As such, in 
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relation to existing diagnostic categories, transdiagnostic approaches may improve 
research (Caspi, et al., 2014). 
As with autism, clinicians once thought that a person either “had” or “didn’t have” 
this condition, but it is now well known that autistic symptoms (just like those of 
ADHD) are arrayed on a continuum (Posserud, Lundervold, & Gillberg, 2006). This 
“spectrum” notion raises the provocative idea that a large number of people without 
diagnosable ADHD may benefit from ADHD-linked treatments, like medication. 
This contention is the source of major controversy in light of the diversion of 
stimulants to those without a diagnosis. It also means that many people have “a bit” 
of ADHD (or, for that matter, of depression or autism), a truth that, when it becomes 
better known, could have implications for reducing stigma (Hinshaw & Scheffler, 
2014). 
Awareness of heterogeneity is especially crucial for understanding relations between 
development and psychopathology, because developmental changes and differences 
are so incompatible with static diagnostic categories. By contrast, hierarchical 
dimensional models can take account of heterogeneity, potentially important 
similarities, individual differences, and developmental changes in psychopathology 
(Achenbach, 2015). The Hierarchical Taxonomy of Psychopathology (HiTOP) is a 
dimensional alternative to traditional nosologies (Kotov, et al., 2017). HiTOP is a 
collaborative effort of nosologists from various mental health disciplines to improve 
the organization, description and measurement of psychopathology. Its objectives are 
to advance the classification of psychopathology to maximize its usefulness for 
research and clinical practice. The HiTOP aims to address limitations of traditional 
nosologies, such as the DSM-5 and ICD-10, including arbitrary boundaries between 
psychopathology and normality, often unclear boundaries between disorders, frequent 
disorder co-occurrence, heterogeneity within disorders, and diagnostic instability 
(https://medicine.stonybrookmedicine.edu/HITOP).  
In a response to the longstanding problematic lack of biologically meaningful 
psychiatric diagnoses, the National Institute of Mental Health in the USA has 
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launched the Research Domain Criteria (RDoC) initiative (Bruce N. Cuthbert, 2014; 
B. N. Cuthbert & Insel, 2013; Morris & Cuthbert, 2012). Perhaps the most important 
point about RDoC is that its essence is to provide a broad framework for conducting 
research on mental disorders from a wholly new perspective. In this sense, what is 
most important about RDoC is not the list of constructs and the matrix per se, but the 
idea of freeing up investigators to pursue exciting translational research questions 
driven by neuroscience and behavioral science rather than by constraining sets of 
symptom clusters (Bruce N. Cuthbert, 2014). Disorders may be the product of shared 
risk factors that lead to abnormalities in intersecting drives such as motivation and 
reward anticipation, which can be measured and used to place people on one of 
several dimensions (Adam, 2013). 
In applying this new model to mental health research, a key first step is to identify 
and systematically examine transdiagnostic symptom dimensions that are both 
clinically meaningful and amenable to RDoC mapping. Aggressive behavior and 
violence, along with related tendencies (e.g., anger, hostility), are observed in persons 
with various mental health problems (Verona & Bresin, 2015), and may serve as a 
transdiagnostic symptom dimension. Insomnia may be another meaningful 
transdiagnostic process, as a process that is common across diverse psychiatric 
disorders (Allison G. Harvey, 2008). 
4.4 Patients have impairments, not purely symptoms 
An important element to consider here is that whereas we in research generally are 
more concerned with symptoms, wanting pure dimensions that span from the normal 
range to the extreme, in reality, clinical patients are hallmarked by their functional 
impairment, criterion D of the ADHD diagnosis (Gordon et al., 2006). Diagnosing 
ADHD based primarily on symptom reports assumes that the number/frequency of 
symptoms is tied closely to the impairment imposed on an individual’s functioning. 
That presumed linkage encourages diagnosis more by DSM style symptom lists than 
well-defined, psychometrically sound clinical assessments. In four separate, large-
scale ADHD research samples the average correlation between symptoms and 
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impairment accounted for less than 10% of variance, and symptoms never predicted 
more than 25% of the variance in impairment (Gathje, Lewandowski, & Gordon, 
2008; Gordon, et al., 2006). When these researchers parsed the ADHD group 
according to a measure of current symptoms, the sample size shrunk by 77% when a 
criterion-based measure of impairment was added. The partial unlinking of symptoms 
and impairment has implications for decisions about the diagnostic process, research 
criteria for participant inclusion, prevalence estimates, gender ratios, evaluation of 
treatment effects, service delivery, and many other issues (Gathje, et al., 2008; 
Gordon, et al., 2006). 
Personally I wonder if not indeed impairment is part of why so many psychiatric 
disorders show shared genetic liability, as a final common pathway/end result, and 
indeed may be orthogonal to more “successful” adaptations of “extreme” ends of 
traits and behavioral dispositions. Such as being highly energetic, perhaps similar to 
an “ADHD” phenotype but not impairing to a group of highly successful people, who 
are able to harness this otherwise volatile energetic disposition.  
4.5 Nature has not read the DSM 
Classifications are cognitive structures imposed on data to achieve particular goals. 
Given the complexity of human psychology, biology, and illness, any classification in 
these realms is likely to be plagued by stubborn bits of data that refuse to fit neatly 
into uniform, well-ordered classes (Hyman, 2010). The current diagnostic framework, 
established with the DSM-III in 1980, has served both research and clinical practice 
in the decades that have elapsed since its inception (Morris & Cuthbert, 2012). It is 
difficult to imagine anything like the advances that have occurred over that time 
without having a common language and set of diagnostic referents. As diagnosis 
across all areas of medicine accelerates into an age of genetics and microbiology for 
understanding disease trajectories, the very success of the DSM/ICD approach is 
perhaps the major obstacle to considering substantive changes (Morris & Cuthbert, 
2012). As genetic research progresses and the lines between established categories 
are blurred out, I expect future nosologies will look quite different than they do today 
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(Adam, 2013; Cross-Disorder Group of the Psychiatric Genomics, 2013; Cross-
Disorder Group of the Psychiatric Genomics, et al., 2013). 
Comorbidity has been found to be so extensive among DSM-IV diagnoses as to 
forcefully raise questions about the underlying structure and assumptions of the 
classification system (Hyman, 2010). The open question raised by these observations 
is whether individuals with comorbidity within a family of disorders are better 
understood as having two or more distinct DSM disorders or as having a single 
disorder in which complex etiological factors give rise to diverse symptom 
complexes that may change with time and environmental exposures (Hyman, 2010). 
The reliance on biologically heterogeneous categories as the gold standard for 
diagnosis has clearly precluded the identification or validation of biomarkers. 
Although one could imagine revising the diagnostic categories to align with 
biological discoveries, so far the field has essentially excluded biological findings 
that do not map on to the current heterogeneous categories of symptom clusters (B. 
N. Cuthbert & Insel, 2013). The stark reality is that no one has yet agreed on how 
best to define and diagnose mental illnesses. DSM-5, like the two preceding editions, 
places disorders in discrete categories such as major-depressive disorder, bipolar 
disorder, schizophrenia and obsessive–compulsive disorder (OCD). These categories, 
which have guided psychiatry since the early 1980s, are based largely on decades-old 
theory and subjective symptoms (Adam, 2013).  
However, introducing new nosological systems invites the creation of competing 
diagnostic systems, which in turn limit the comparability and generalizability of 
scientific research findings (McGough & Barkley, 2004). I think this is an important 
caveat, which may help explain why clinicians and clinical researchers may be 
reluctant to changing nosologies and abandon established categories. Even as science 
progresses, the implementation of new findings and conceptualizations in clinical 
practice may take time. Thus, it could be beneficial, as I have tried during the thesis, 
to underline the historical currents of divergent perspectives on diagnostic nosology, 
as a reminder that the currently supported findings do not necessarily represent an 
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entirely new way of thinking, but rather confirming other, and unexpected departures 
from what over time has become mainstream ways of thinking, and consequently 
diagnosing and treating patients. 
The successive editions of the DSM and ICD have revised the categories and criteria 
in hope of better discriminating between what were assumed to be hundreds of 
discrete disorders. However, the once plausible goal of identifying homogeneous 
populations for treatment and research has resulted in narrow diagnostic categories 
that do not capture clinical reality, symptom heterogeneity within disorders, and 
significant sharing of symptoms across multiple disorders. The historical aspiration of 
achieving diagnostic homogeneity by progressive subtyping within disorder 
categories no longer seems sensible. Like most common human ills, mental disorders 
are heterogeneous at many levels, ranging from genetic risk factors to symptoms 
(American Psychiatric Association, 2013). Despite the problems posed by categorical 
diagnoses, the DSM-5 Task Force concluded that it was scientifically premature to 
propose alternative definitions for most disorders at the time when the DSM-5 was 
published (American Psychiatric Association, 2013). Thus, in the latest version of the 
DSM, the organizational structure is retained to serve as a bridge to new diagnostic 
approaches without disrupting clinical practice or research (American Psychiatric 
Association, 2013).  
4.6 Strengths and limitations 
The studies in this thesis are mainly based on an adult ADHD sample ascertained in 
adulthood, meaning that it is uncertain whether the patients included would have 
obtained a childhood diagnosis of ADHD, and showed an expected symptomatic 
trajectory. This is important to note, as some recent studies have put into question the 
idea of ADHD as a neurodevelopmental disorder, highlighting both discontinuation 
of childhood symptoms as well as a possible adult onset ADHD phenotype (Agnew-
Blais et al., 2016; Caye, Rocha, Anselmi, & et al., 2016; T. E. Moffitt et al., 2015). 
However, in paper III, our findings of a genetic association with an aggressiveness 
phenotype was replicated in a childhood ADHD sample, with promising results. The 
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adult patient samples used in the three papers were clinically ascertained and are 
likely to represent this patient group. The Norwegian adult ADHD sample had no 
formal exclusion criteria, allowing for an ecologically representative group of 
diverse, heterogeneous patients that you would find in the clinic. However, these 
patients were based on their impairments, leading them to seek out treatment, and not 
purely their symptoms as discussed above. The population controls were randomly 
selected from the Medical Birth Registry of Norway, giving a representative picture 
of their age group. The controls were also not subject to any exclusion criteria. Thus, 
a strength of this study is that we find a normally distributed range of ADHD 
symptoms, as displayed in paper I, with some patients having a symptomatic load 
above what we would define as a clinical threshold. Possibly these are indeed “false 
negatives”, i.e. people with ADHD who should have sought treatment. Or perhaps 
some of these individuals represent a group with a “true high ADHD symptom 
score”, but without the clinically important aspect of impairment. This uncertainty 
allows for a dimensional approach, in line with modern diagnostic alternatives.   
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5. CONCLUSION 
The results in the present thesis suggest that we need to broaden our approach and 
scope when investigating and treating patients with ADHD. We need to go beyond 
the classic symptom domains of inattention, hyperactivity and impulsivity, and 
recognize that patients qualifying for an ADHD diagnosis also have other, important 
impairing symptom domains. Other domains, e.g. aggressiveness, insomnia and 
learning problems, also need to be addressed in order to successfully help the adult 
ADHD patient. The complexity of impairment characterizing patients with ADHD, 
with executive dysfunction, emotional lability, insomnia, aggressiveness, dysthymia, 
and a host of other problems indicate that the narrow symptom domains defined as 
the core ADHD symptoms in the current DSM may in future revisions have to be 
broadened, expanded or changed/reconceptualized to better fit the empirical reality of 
the patients suffering from severe impairment.  
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6. FUTURE PERSPECTIVES 
The present thesis indicates that executive dysfunction (Adler et al., 2017; Ustun et 
al., 2017) such as inattention, affective dysregulation (Adler, et al., 2017; Haavik, et 
al., 2010; Shaw, Stringaris, Nigg, & Leibenluft, 2014) exemplified by aggressiveness, 
and insomnia (Allison G. Harvey, 2008) are all central to the ADHD phenotype. Such 
evidence might point to a shifting recognition in the future diagnostic systems 
towards a landscape that is more complex and multifaceted than what is currently 
listed as core symptomatic criteria in the DSM. This is more in line with the p-factor 
(Caspi, et al., 2014), ESSENCE (Gillberg, 2010), HiTOP (Kotov, et al., 2017) and 
RDOC (Bruce N. Cuthbert, 2014) approaches, where the presence of what we now 
identify as ADHD may instigate the clinician towards performing a broader 
diagnostic evaluation in order to capture the complete picture of the patients’ 
impairing symptomatic domains. Increasingly, a range of disorders are recognized as 
dysregulations of normal processes (Adam, 2013). Perhaps these features can inspire 
novel treatment interventions and better patient care by introducing meaningful and 
important perspectives. Sometime in the future we may have a new field of precision 
psychiatry (Fernandes et al., 2017), based on increased insight into the underpinnings 
of human behavior. However, an important point that is often not taken seriously 
enough in a present characterized by rapid advances in neuroscience, is the 
importance of careful theoretical and experimental distillation of behavior (Krakauer, 
Ghazanfar, Gomez-Marin, MacIver, & Poeppel, 2017). An example discussed earlier 
is the lack of a consensus regarding the definition of aggressiveness (Ramirez & 
Andreu, 2006). Detailed analysis of tasks and the behavior they elicit is important for 
discovering the component processes and their underlying algorithms. There are no 
short-cuts in the trajectories from psychology, cognition, perception and behavior to 
neurons and circuits, not to mention larger sociohistorical contexts and their 
influences on behaviors and brains. A correction to a reductionist bias in the 
neurosciences and in psychiatric research is not only welcome, but necessary if we 
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Abstract 
Introduction: Adult Attention Deficit Hyperactivity Disorder (ADHD) is a 
neurodevelopmental disorder characterized by symptoms of inattention and 
hyperactivity/impulsivity. The present study investigated the psychometric properties of two 
commonly used screening instruments for adult ADHD; the Wender Utah Rating Scale 
(WURS) and the Adult ADHD Self-report Scale (ASRS).  
Methods: The sample contained adults with clinically confirmed ADHD (n = 646) and 
population controls (n = 908). The 25 item WURS retrospectively assessed childhood 
symptoms. The ASRS assessed the 18 current defining symptoms of ADHD. Principal 
component analyses (PCA) examined the factor structure of the two instruments and area 
under the curve (AUC) analyses assessed discriminatory properties. Likelihood ratios (LH) 
and diagnostic odds ratios (DOR) were calculated to quantify the discriminatory abilities.  
Results: PCA confirmed the two factors of inattention and hyperactivity/impulsivity of the 
DSM while PCA of the WURS yielded three factors labeled Aggression and social problems, 
Learning and attention problems and Dysthymia. AUC of both WURS (.96, 95% CI: .95-.97) 
and ASRS (.90, 95% CI: .89-.92) were large, and both discriminated well between adults with 
ADHD and controls.  
Conclusion: Both the WURS and the ASRS had excellent properties in identifying adult 
ADHD, with WURS being superior to the ASRS, possibly because the WURS encompasses a 
broader range of symptoms than is contained by the DSM, most notably learning problems 
and aggressiveness. 
 
Key-words: Adult ADHD, Screening Properties, Retrospective Self-Report, Childhood 
Symptoms, Persistent ADHD, Psychometric properties, ASRS, WURS  
 
Introduction 
Adult Attention Deficit Hyperactivity Disorder (ADHD) is a persistent neurodevelopmental 
disorder with childhood onset, characterized by inattention, hyperactivity and impulsivity [1]. 
ADHD has a prevalence of about 5% in childhood [2], with about half persisting into 
adulthood [3]. However, because contextual demands increase with age, ADHD is often first 
recognized in adults [4]. Fayyad, Sampson [5] found an overall prevalence of 2.8 % of DSM-
IV adult ADHD across a range of nations, spanning from 1.4% in lower income countries to 
3.6% in higher income countries. Adult ADHD is associated with e.g. lower educational 
achievement, incarcerations, unemployment and illicit drug use [3]. Clinical assessment based 
on the Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria is the gold 
standard for the diagnosis [6], but short screeners or symptom rating scales provide a quick 
and easy way of obtaining standardized information to select patients for further examination.  
 
It is important to establish a history of childhood ADHD symptoms, as the pharmacological 
treatment of ADHD involves regulated substances and as several other disorders that appear 
in adulthood may display ADHD symptoms (e.g. affective disorders, substance use disorders 
and sleep disorders) [6]. To add to the complexity, these disorders may often also be 
comorbid with ADHD. The Wender Utah Rating Scale (WURS) was developed to 
retrospectively evaluate the presence and severity of childhood symptoms of ADHD in adult 
patients [7]. The WURS is based on the Utah criteria [8], requiring a childhood history of 
ADHD including both inattentive and hyperactive symptoms, with one of the following 
additional symptoms: behavior problems in school, impulsivity, over-excitability and temper 
outbursts. Secondly, it requires an adult history of persistent attention problems and motor 
hyperactivity with at least two of the following symptom domains: affective lability, hot 
temper, stress intolerance, disorganization and impulsivity [7]. The original 61 item 
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questionnaire was subsequently reduced to the 25 items that best distinguished an ADHD 
sample from control samples (i.e. healthy controls and depressed patients). Most of the final 
25 items are thus not directly tapping into the core ADHD symptoms, but were chosen for 
their discriminative ability. A WURS-25 score of at least 36 identified 96% of adults with 
ADHD and 96% of healthy controls [7]. A cutoff of 46 or higher correctly identified 86% of 
adults with ADHD, 99% of “normal” controls, and 81% of a comparison sample with 
depression. Several authors have reported a 3-factor structure of the WURS under somewhat 
different names. McCann, Scheele [9] named the factors Dysthymia, Oppositional/Defiant 
Behavior, and School Problems while Caci, Bouchez [10] named the factors 
Impulsivity/Temper, Inattentiveness, and Mood/Self-esteem. Caci, Bouchez [10] also found 
moderate correlations between WURS and ASRS. Stanton and Watson [11] recently reported 
factors Aggression, Internalizing Distress, and Academic Difficulties of the WURS in a 
community sample.  
 
Current symptoms of inattention and/or hyperactivity and impulsivity are also essential for the 
diagnosis of ADHD to be made in adulthood. The Adult ADHD Self-Report Scale (ASRS) is 
the official screening instrument of the World Health Organization (WHO) [12], and includes 
the 18 items ADHD symptoms of the DSM. It is one of the most commonly used screening 
instruments of current ADHD symptoms in adults. The authors/creators of the ASRS tested 
several variants of administering the 18 DSM symptoms of ADHD, and concluded that a 6-
item version was best suited as general population screen [12, 13]. The authors based their 
conclusion on blind clinical ratings of DSM-IV adult ADHD in a sample of merely 154 
respondents from the US National Comorbidity Survey Replication (NCS-R), oversampling 
those who reported childhood ADHD and adult persistence [12]. Recently, the same group 
[14] created an updated 6-item screen of the ASRS replacing two of the 6 items with items on 
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executive functioning (i.e. not part of the ADHD defining symptoms). They found this to 
have good psychometric properties as a general population screener. However, another small 
non-clinical study comparing the short screener to the full 18 items version found the lengthy 
version to have better psychometric properties [15]. The authors pointed out the need for a 
direct assessment of the utility of the ASRS in clinical samples, as there is a lack of studies 
examining the screening properties of the whole ASRS in an adequately large sample of 
adults with a clinically confirmed ADHD diagnosis and population controls.  
 
The aims of the present study were threefold; First, to establish the validity of the Norwegian 
translations of the WURS and the ASRS using factor analyses. Second, to examine the 
psychometric properties of the WURS and the ASRS in a large clinically diagnosed adult 
ADHD patient sample and population controls. Third, to compare the utility of these 




The participants were recruited as part of the “ADHD in Norwegian Adults” project launched 
in 2004 with the aim to improve knowledge about ADHD in adults concerning etiology, 
diagnosis, and treatment. The ADHD sample constitute a well-validated group, mainly 
recruited from a national registry of adults diagnosed in Norway from 1997 to May 2005. The 
diagnostic assessment was made by expert committees according to the 10th revision of the 
International Statistical Classification of Diseases and Related Health Problems (ICD-10) 
[16], with allowances for the subtypes described in the DSM-IV-TR [17]. This was 
mandatory at that time in Norway for adults to be considered for stimulant treatment. To 
increase the sample, clinicians nationwide were thereafter asked to refer adults with ADHD 
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according to the same procedures as the one used by the expert committees. The control 
sample (18-40 years old at the time of recruitment) was randomly selected from the Medical 
Birth Registry of Norway (MBRN). The present study included n = 646 clinically assessed 
adult ADHD patients and n = 908 controls, resulting in a total sample of 1,554 participants. 
The mean age in the control group was 29.4 (7.8) years and 34.0 (10.3) years in the ADHD 
group. There were 59.9% females in the control sample and 48.5% in the ADHD group. For a 
subset of patients, we also obtained clinician ratings on whether the patients were currently on 
(n = 420) or off (n = 125) pharmacological treatment for ADHD, as well as if they had been 
treated for ADHD as a child (n = 89) or not (n = 530). The study was approved by the 
regional committee for medical and health research ethics, Western Norway. 
 
Instruments 
The Wender Utah Rating Scale (WURS)  
The 25-item version of the WURS [7] assesses childhood symptoms by asking the 
participants to retrospectively recall the frequency and severity of ADHD symptoms and 
related problems experienced in childhood. Participants responded to these items using a 
Likert type 5-point scale according to the following response categories: “not at all/very 
slightly” (0), “mildly” (1), “moderately” (2), quite a bit” (3), or “very much” (4), giving a 
possible range of 0-100 points.  
 
The Adult ADHD Self-Report Scale (ASRS) 
The ASRS is a brief screening instrument to identify current ADHD symptoms [12]. The 
scale was developed by the World Health Organization [16] and the Work Group on Adult 
ADHD [12]. The scale contains the 18 symptoms defining ADHD according to the DSM-IV-
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TR and DSM-5 [1, 17]. The severity of the symptoms are reported on a 5-point Likert-type 
scale (0-4 = never, rarely, sometimes, often, to very often), with a total range of 0 to 72. 
The ASRS used in the present study was divided into a part A representing symptoms of 
inattention, and a part B representing symptoms of hyperactivity and impulsivity. The total 
ASRS score has shown good reliability and validity in both clinical and population samples 
[18, 19].  
 
Statistics and analytic plan 
A Principal Component Analysis (PCA) with Varimax rotation was run to determine the 
latent structure of the WURS and the ASRS, selecting factors with Eigenvalues above one. 
We calculated receiver operating curves (ROC) including Area Under the Curve (AUC) for 
the full WURS and ASRS, as well as for the PCA generated factors. The AUC is a preferred 
measure of concordance rather than Cohen’s κ because AUC, unlike κ, is not influenced by 
prevalence [13].  
The likelihood ratios for positive tests (LH+) and negative tests (LH-) and Diagnostic Odds 
Ratio (DOR) were calculated using formulas from Fischer, Bachmann [20]. The DOR  is a 
measure of a diagnostic test’s overall accuracy [21], and unlike positive and negative 
predictive values, the DOR does not depend on the prevalence of the disease, facilitating 
comparisons of tests for meta-analyses. A DOR value of 20 or more indicates that an 
instrument has useful screening properties [20]. 
Cronbach’s alpha was calculated to measure internal consistency in the resulting factors of the 




The total scores of WURS and ASRS were strongly correlated (full sample r = .78, p < .001; 
ADHD group r = .36, p < . 001; Controls r = .70 , p < .001). Figure 1 shows the distributions 
of WURS and ASRS scores in the ADHD and control samples, including the correlation 
between the two. Mean scores on the ASRS were 45.0 (12.6) and 23.0 (9.8) among the 
ADHD group and control group (p < .001), respectively. For the WURS the mean scores were 
58.2 (17.9) and 17.3 (13.9) (p < .001), respectively. The subset of adults with ADHD on 
current pharmacological treatment reported a significantly lower ASRS score 43.5 (13.3) than 
the off treatment group 48.1 (10.4) (p < .001). There was no difference between on the groups 
on versus off pharmacological treatment on the WURS, 58.0 (18.3) versus 58.6 (17.0), 
respectively. There were significant differences between the patients who had been treated for 
ADHD as a child compared with those who had not on both the WURS and ASRS; Patients 
treated in childhood scored 55.1 (18.9) on the WURS versus 32.5 (25.2) (p < .001) for those 
who had not received treatment in childhood. On the ASRS patients treated as children scored 
41.5 (12.7) versus those who were not 31.4 (14.4) (p = .003).  
 
Factor analyses 
The Principal Component analysis generated a three-factor solution to the WURS in the full 
sample (Table 1) explaining 69.2% of the variance. This solution offered high item loadings 
on each scale, with a few exceptions. The highest loading items on the first factor were 
“Temper outbursts, Tantrums” and “Angry”, including items of defiant behavior. The highest 
loading items on the second factor were “Overall a poor student, Slow learner” and “Trouble 
with mathematics or numbers”, also including items of inattention. The items with the highest 
loading on the third factor were “Anxious, Worrying” and “Sad or blue, Depressed, 
Unhappy”. We thus named the three factors Aggressiveness and social problems, Learning 
and attention problems and Dysthymia, respectively. Only the item “Unpopular with other 
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children […]” had ambiguous loading with factor loadings below .50 on all factors. Internal 
consistency measured by Cronbach’s alpha was .967 for the full WURS, and .954 for Anger 
and social Problems, .919 for Learning and attention problems and .897 for Dysthymia, 
respectively.  
 
A two-factor solution was generated for the ASRS in the full sample (Table 2), explaining 
62.2% of the variance. The first factor included items reflecting symptoms of inattention, the 
second factor symptoms of hyperactivity and impulsivity. The items reflecting impulsive 
behavior obtained the highest loadings on the second factor.  
Internal consistency measured by Cronbach’s alpha was .952 for the full ASRS score, .924 for 
the Inattentive factor and .918 for the Hyperactivity/Impulsivity factor.  
 
The discriminative ability of the WURS and the ASRS  
Figure 2 illustrates the discriminatory values of both the WURS and the ASRS, with an AUC 
of .956 (95% CI: .946 - .965) for the WURS, and .904 (95% CI: .888 - .921) for the ASRS. 
The optimal cut-off balancing the trade-off between sensitivity and specificity for the 
respective scales may vary depending on the aims in the specific clinical or research setting. 
Table 3 provides cut-off values for 98%, 95%, 90% and 80% sensitivity and specificity, 
respectively, for both the WURS and the ASRS, including LHs and DORs for each cut-off. 
Our findings fit well with the cut-off of 36 suggested by Ward, Wender [7] and the cut-off 
value of 37 for the full 18 item ASRS suggested by Kessler, et al. [12]. Using sum scores 
from all the factors extracted from PCA, Learning and attention problems had the highest 
AUC of .95 (95% CI .94 - .96), followed by Aggressiveness and social problems with .93 




Both the WURS and the ASRS had excellent screening and psychometric properties, with 
somewhat stronger properties for the WURS. The results confirmed the three-factor structure 
of the WURS only differing somewhat at item level [9-11]. The ASRS had the expected two-
factor structure. Our findings fit well with previous cut-off suggestions by Ward, Wender [7] 
for the WURS and by Kessler, et al. [12] on the full 18 item ASRS (Table 3). Contrary to the 
critique raised against the WURS for lacking content validity (i.e. diverging from the DSM 
symptom criteria) [11], we found a very high criterion validity of WURS (i.e. being highly 
predictive of an ADHD diagnosis). Furthermore, the very items driving this discriminatory 
ability were part of the Learning and attention problems factor of the WURS. The items 
represent behaviours well recognized as core ADHD symptoms (WURS 1: Concentration 
problems, Easily distracted and WURS 7: Trouble with stick-to-it-tiveness, not following 
through, failing to finish things started). 
 
The delineation of disorder versus normality is a universal problem when a diagnosis is based 
on symptoms that are dimensional and normally distributed, but it is of particular concern in a 
disorder for which controlled stimulant substances with potential for abuse are first-line 
treatments [23]. Thus, our study is important in that it addresses the psychometric properties 
of two commonly used screening instruments employed in parallel on a well-validated sample 
including both clinically ascertained adult ADHD patients and a population control sample. 
Our findings add to the ongoing controversy of what the optimal defining features of adult 
ADHD are. Adler, Faraone [24] suggested that executive dysfunction is as central as the 
DSM-5 symptoms to adult ADHD, while emotional dysregulation has been suggested to be 
more distinct but nevertheless part of the combined presentation of adult ADHD [6, 25]. In 
the present study, the WURS had better discriminatory properties than the ASRS. This is 
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noteworthy as our patients were diagnosed as adults based on a comprehensive clinical 
evaluation following the ICD/DSM criteria. Thus, even strictly defined adult ADHD patients 
are more easily distinguished from controls with a broader childhood symptom array than the 
current DSM core symptoms. This fits well with the well-established finding that ADHD is 
characterized by symptoms within domains of executive problems and emotional 
dysregulation. Although traditionally viewed as comorbid problems, these symptoms may 
rather be characteristic of having ADHD itself. The broader aspect covered by the WURS 
may reflect the broader picture that is essentially characteristic of persistent ADHD. 
 
Possibly the retrospective focus of the WURS evoking a developmental frame and spanning 
over a longer period of time may elicit responses that separate better between adult patients 
with ADHD and controls. Another possible explanation for the better screening properties of 
the WURS could be that some of the patients have ADHD in partial remission (and thus a low 
ASRS score). However, we found that adult ADHD patients on current pharmacological 
(mainly stimulant) treatment reported less current symptoms of ADHD compared to those 
who were not on medication, but no differences on the WURS. Furthermore, patients treated 
for ADHD in childhood reported more symptoms than those who had not been treated in 
childhood on both the WURS and the ASRS, indicating a more severe and persistent 
phenotype [26].  
 
Strengths and limitations 
These findings should be viewed in light of some limitations. There are obvious problems 
related to the use of self-report measures. Measures that employ a retrospective approach 
might be affected by memory biases and lack of recall. McGough and Barkley [23] argued 
that ”a major obstacle to retrospective diagnosis is that it is significantly biased by current 
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functioning”. However, our findings show that the retrospective WURS did better than reports 
of current ADHD symptoms in differentiating adult ADHD patients from controls. This is in 
line with previous studies on the WURS by e.g. Fossati, Di Ceglie [27] showing excellent 
short-term retest reliability. Both Fossati, Di Ceglie [27] and Grogan and Bramham [28] 
found  that current mood symptoms do not affect the accuracy of retrospective self-ratings of 
childhood ADHD symptoms. The ASRS on the other hand may be more affected by short 
term confounders such as affective fluctuations [29], time of day [30] and sleep problems [31, 
32]. We did not attempt to control for comorbidities, as ADHD is more often comorbid than 
not (e.g. Singh [33], Sobanski [34]). 
 
We used a clinically validated patient sample and a representative population control sample, 
which strengthens the clinical utility of our findings. Our control sample was randomly 
recruited from the Norwegian Medical Birth Registry, without any formal exclusion criteria, 
so there is a potential for some undiagnosed cases of ADHD in this group.  
 
Conclusion 
Diagnosing ADHD in adults requires information about childhood symptoms in addition to 
current symptoms, impairments and functioning. Although the WURS differs from the ASRS, 
both had excellent psychometric properties. Including symptoms beyond the core ADHD 
symptoms, the WURS has been criticized for lacking validity. However, the WURS was not 
only highly accurate in separating ADHD patients from controls, but had even better 
screening properties than the ASRS. This in spite of our sample being clinically assessed in 
adulthood. The findings support a broader conceptualization of ADHD in line with the Utah 
tradition, as the three factors of the WURS picked up dimensions that were highly relevant to 
identify adult ADHD in our sample. With their different temporal focus and clinically 
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relevant symptom domains, we recommend using the ASRS and the WURS jointly in 
screening for adult ADHD.
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Figure 1: Distribution of WURS and ASRS scores in the ADHD and control samples.  
 
Top left: Distribution of ASRS scores. Bottom left: Distribution of WURS scores. Right: 
Overlap between scores on the WURS and ASRS. Controls are green. ADHD patients are 
blue. Lines represent a cut-off score of 35; vertical line for WURS, horizontal line for ASRS. 
This gives a sensitivity of .90 and specificity of .88 for the WURS, and a sensitivity of .80 and 




Figure 2: Receiving operator curve illustrating the psychometric properties of the WURS and 
the ASRS in predicting adult ADHD status. 
 
Blue line represents the WURS. Green line represents the ASRS. A steeper curve indicates 
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Table 1: Rotated Factor Component Matrix for the WURS 
Table 2. Rotated Factor Component Matrix for the ASRS 






Table 1: Rotated Factor Component Matrix for the WURS 
  
As a child I was (or had): 
Component 
1 2 3 
Aggressiveness and Social Problems (30.7% of the variance) 
WURS 6: Temper outbursts, Tantrums 
.817 .204 .235 
WURS 14: Angry  .811 .172 .318 
WURS 5: Hot- or short-tempered, Low boiling point .785 .242 .261 
WURS 10: Disobedient with parents, Rebellious, Sassy .746 .214 .137 
WURS 19: Losing control of myself .740 .342 .328 
WURS 12: Irritable .738 .247 .401 
WURS 8: Stubborn, Strong-willed .673 .242 .475 
WURS 13: Moody, Ups and downs .672 .403 .336 
WURS 20: Tendency to be or act irrational .662 .154 .090 
WURS 15: Trouble seeing things from someone else's point of view .652 .390 .115 
WURS 22: Trouble with authorities, trouble with school, visits to 
principal's office 
.635 .374 .230 
WURS 16: Acting without thinking, Impulsive .621 .559 .234 
WURS 21: Unpopular with other children, didn't keep friends for 
long, didn't get along with other children 
.467 .349 .433 
Learning and Attention Problems (19.5% of the variance) 
WURS 23: Overall a poor student, slow learner 
.229 .783 .195 
WURS 24: Trouble with mathematics or numbers .147 .757 .209 
WURS 25: Not achieving up to potential .312 .730 .370 
WURS 1: Concentration problems, Easily distracted .459 .694 .310 
WURS 7: Trouble with stick-to-it-tiveness, not following through, 
failing to finish things started 
.369 .595 .427 
WURS 4: Inattentive, Daydreaming .519 .587 .330 
WURS 17: Tendency to be immature .432 .542 .308 
Dysthymia (19.0% of the variance) 
WURS 2: Anxious, worrying 
.200 .240 .814 
WURS 9: Sad or blue, depressed, unhappy .313 .151 .799 
WURS 11: Low opinion of myself   .166 .265 .754 
WURS 18: Guilty feelings, regretful .230 .280 .728 
WURS 3: Nervous, fidgety .334 .377 .684 
 
PCA with Varimax rotation on the WURS in the full sample. 





Table 2. Rotated Factor Component Matrix for the ASRS  
Circle the number that best describes how you have felt and conducted yourself  
over the past 6 months 
Component
1 2 
Inattentive (34.0% of the variance)   
ASRS5 How often do you have difficulty getting things in order when you have to  
do a task that requires organization? 
.794 .263
ASRS2 How often do you have difficulty keeping your attention when you are doing 
boring or repetitive work? 
.753 .373
ASRS6 When you have a task that requires a lot of thought, how often do you avoid  
or delay getting started? 
.739 .291
ASRS1 How often do you make careless mistakes when you have to work on a boring 
or difficult project? 
.735 .327
ASRS4 How often do you have trouble wrapping up the fine details of a project, once 
the challenging parts have been done? 
.721 .394
ASRS3 How often do you have difficulty concentrating on what people say to you,  
even when they are speaking to you directly? 
.679 .413
ASRS7 How often do you misplace or have difficulty finding things at home or at 
work? 
.662 .230
ASRS9 How often do you have problems remembering appointments or obligations? .655 .264
ASRS8 How often are you distracted by activity or noise around you? .654 .437
Hyperactive/Impulsive (28.2% of the variance) 
ASRS15 How often do you find yourself talking too much when you are in a social 
situation? 
.209 .761
ASRS16 When you’re in a conversation, how often do you find yourself finishing the 
sentences of the people that you are talking to, before they can finish them themselves? 
.236 .749
ASRS17 How often do you have difficulty waiting your turn in situations when turn-
taking is required? 
.371 .740
ASRS18 How often do you interrupt others when they are busy? .305 .731
ASRS14 How often do you feel overly active and compelled to do things, like you  
were driven by a motor? 
.394 .684
ASRS12 How often do you feel restless or fidgety? .579 .595
ASRS11 How often do you leave your seat in meetings or other situations in which  
you are expected to remain seated? 
.502 .577
ASRS13 How often do you have difficulty unwinding and relaxing when you have  
time to yourself? 
.478 .574
ASRS10 How often do you fidget or squirm with your hands or your feet when you 
have to sit down for a long time? 
.514 .567
   
PCA with Varimax rotation on the ASRS in the full sample. 
62.2% Variance explained in the full sample rotated factor solution. Items sorted by factor 
loadings. 
 
Table 3. Predictive validity of the WURS and the ASRS. 
 
Complimentary Specificity/Sensitivity given in parenthesis.  
 
WURS = Wender Utah Rating Scale 
ASRS = Adult ADHD Self-Report Scale 
 
LH+ = Likelihood ratio positive test 
LH- = Likelihood ratio negative test 
DOR = Diagnostic Odds Ratio 
 
 
 WURS   ASRS   
Sensitivity  (Specificity) LH+ LH- DOR (Specificity) LH+ LH- DOR 
.98 21 (.71) 3.38 0.03 135.5 16 (.22) 1.26 0.09 14.6 
.95 29 (.83) 5.59 0.06 95.6 21 (.45) 1.73 0.11 18.0 
.90 35 (.88) 7.50 0.11 64.7 27 (.71) 3.10 0.14 23.6 
.80 42 (.93) 11.43 0.22 56.1 35 (.88) 6.67 0.23 30.8 
Specificity  (Sensitivity)    (Sensitivity)    
.98 56 (.55) 27.5 0.46 53.4 49 (.45) 22.5 0.56 34.0 
.95 46 (.75) 15 0.26 54.5 42 (.64) 12.8 0.38 32.7 
.90 36 (.89) 8.9 0.12 63.5 36 (.79) 7.9 0.23 32.0 
.80 26 (.97) 4.85 0.04 117.3 30 (.88) 4.4 0.15 27.8 
Paper II 
 
Prevalence and clinical correlates of
insomnia in adults with attention-deficit
hyperactivity disorder
Brevik EJ, Lundervold AJ, Halmøy A, Posserud MB, Instanes JT,
Bjorvatn B, Haavik J. Prevalence and clinical correlates of insomnia in
adults with attention-deficit hyperactivity disorder
Objective: To investigate the prevalence of insomnia in adults with
Attention-deficit hyperactivity disorder (ADHD) and its association
with clinical subtypes, current ADHD symptoms, and stimulant
treatment.
Method: We obtained diagnostic information, symptom rating scales
and treatment history from clinically ascertained adult ADHD patients
diagnosed according to DSM-IV criteria (n = 268, mean age 38.1 years)
and randomly selected population controls (n = 202, mean age
36.5 years). The Bergen Insomnia Scale (BIS) was used to measure
insomnia. ADHD symptom domains were self-rated using the Adult
ADHD Self-Rating Scale.
Results: Insomnia was far more frequent among adults with ADHD
(66.8%) than in the population controls (28.8%) (P < 0.001). Insomnia
was more common in adults with the combined subtype than in those
with the inattentive subtype (79.7% and 55.6%, respectively)
(P = 0.003). For self-reported current ADHD symptoms, inattention
was strongly correlated to insomnia. Patients currently using stimulant
treatment for ADHD reported a lower total insomnia score compared
to patients without medication (P < 0.05).
Conclusion: Insomnia was highly prevalent among adults with ADHD.
The lower insomnia score in patients on current stimulant treatment
suggests that stimulant treatment is not associated with worsening of
insomnia symptoms in adult ADHD patients.
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Significant Outcomes
• Insomnia is highly relevant in adult ADHD, with a fivefold increased risk compared with controls
• Stimulant treatment of ADHD in adults is not associated with worsening of insomnia, and may
potentially even be helpful in alleviating insomnia symptoms
• Insomnia was more common in the combined and hyperactive/impulsive subtypes than in the inatten-
tive subtype
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• Insomnia symptoms were based on self-reports, which may be unreliable and lead to an overestimation
• We do not include other sleep variables which may be of interest
• This study employed a cross-sectional, survey design, limiting the possibility of making causal conclu-
sions.
Introduction
Attention-deficit hyperactivity disorder (ADHD)
is a neurodevelopmental disorder characterized by
symptoms of inattention and/or hyperactivity/im-
pulsivity. Based on these symptom domains, the
Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV/DSM-5) differentiate between
inattentive (IA), hyperactive/impulsive (HI), and
combined subtypes/presentations (1). It is esti-
mated that 2–3% of the adult population suffer
from ADHD (2). People with ADHD typically
struggle with maintaining structure and regulating
their behaviour and daytime activities. The regula-
tory difficulties also seem to affect the diurnal
rhythm, as ADHD has been associated with vari-
ous sleep problems, with insomnia being one of the
most commonly reported comorbid conditions (3).
Insomnia is defined as difficulties initiating or
maintaining sleep, early morning awakenings or
having non-restorative sleep, lasting for at least a
month (1). Insomnia is one of the most frequent
health concerns in the general population as well
(4), typically affecting 6% to 15% of the adult pop-
ulation (5). Insomnia causes irritability and fatigue
as well as reduced productivity, increased absen-
teeism, increased morbidity, and increased health
care costs (4). Most studies examining the relation-
ship between insomnia and ADHD have been per-
formed in children and adolescents, and the few
studies addressing insomnia in adult ADHD have
given conflicting results (6, 7). One study found
that more than half of adults with probable
ADHD fulfilled the criteria for insomnia (8). In
another study, four of five adults with ADHD
reported having sleep problems, irrespective of sex
and subtype (9), indicating the importance of
addressing insomnia in adult ADHD.
It is well established that ADHD is associated
with impairment in cognitive functions such as
attention, vigilance and working memory, as well
as long-term memory, and decision-making (10).
Considering that insomnia also affects cognitive
functioning (9), insomnia in addition to ADHD
may lead to a vicious cycle where impairments are
exacerbated. Studies have shown that sleep prob-
lems in general are associated with inattention,
whereas some specific sleep problems have been
associated with the different ADHD subtypes (3).
According to Gau and Kessler (11), HI has been
associated with decreased sleep duration, whereas
IA has been associated with disturbed sleep,
delayed circadian rhythm, and greater sleep need
(8, 11–14). Meanwhile, the ADHD combined sub-
type is characterized by an overall higher symptom
burden and severity compared with the other sub-
types (15), which may also affect the rate of insom-
nia. Conversely, the severity of sleep problems is
associated with the severity levels of self-reported
ADHD symptoms, both among ADHD patients
and in the general population (11, 16, 17). Among
ADHD patients, this association held when
comorbidity and medication were taken into
account (17). Of the above cited studies, only three
studies (14, 16, 17) used samples with clinically
ascertained ADHD patients, the remaining used
questionnaires to assign ADHD status.
The relationship between sleep problems and
pharmacological treatment for adults with
ADHD is not settled. One study reported that
nearly four of five non-medicated ADHD partici-
pants suffered from sleep-onset insomnia (18),
while other studies have found insomnia to be a
side-effect of treatment with both stimulants (19)
and atomoxetine (20). There is, however, substan-
tial individual variation in whether these medica-
tions cause insomnia or not, and sleep problems
seem to decrease as the medication is titrated and
ADHD symptoms improve (21). Usually, insom-
nia as a side-effect of stimulant treatment attenu-
ates after 1–2 months treatment (22) and ADHD
patients on methylphenidate treatment have even
been found to self-report an improvement in sleep
quality (23).
Thus, although several studies on the relation-
ship between adult ADHD and insomnia have
been published, many of these are of modest qual-
ity, with few participants, unclear inclusion crite-
ria, and lack of validated diagnostic protocols.
Studies using large samples of clinically ascertained
adult ADHD patients and validated measures of
insomnia are therefore needed to clarify the rela-
tionship between insomnia, clinical subtypes, and





The aim of the current study was to determine the
prevalence of insomnia in a large Norwegian sam-
ple of adults with Attention-deficit hyperactivity
disorder (ADHD) compared with population con-
trols. Based on previous findings, we expected
adults with ADHD to experience higher levels of
insomnia than control subjects. We first compared
the prevalence of insomnia in the patient group
with the control group, then in subtypes of
ADHD, and in groups of patients on and off cur-
rent stimulant treatment. Finally, we calculated




This cross-sectional study is part of an ongoing
project on adults with ADHD in Norway
(http://www.uib.no/kgj-npd). The data included
in the present study were collected between 2011
and 2016. The sample included adult ADHD
patients (n = 268), clinically diagnosed by psychi-
atrists and psychologists according to the DSM-
IV criteria (1). All patients were born in Norway
of Norwegian parents. The first patients were
recruited from regional expert committees on
ADHD, subsequent patients were recruited from
clinical psychologists and psychiatrists in out-
patient clinics nationwide. Controls (n = 202)
were randomly selected and invited to participate
in the study directly from the Medical Birth
Registry of Norway. This registry includes all
persons born in Norway from January 1st 1967
(approx. 2.5 million persons at the time of
recruitment). To allow for comorbidities no for-
mal exclusion criteria were used in either sample.
This allowed for considerable comorbidities,
most noticeably in the adult ADHD group
(Table S1). All participants (n = 470) completed
a questionnaire including the six Bergen Insom-
nia Scale (BIS) items, the 18 item Adult ADHD
Self-Rating Scale (ASRS) and questions about
life-time comorbid disorders (e.g., have you ever
had severe anxiety and/or depression). For half
of the patients (n = 135/50.4%) clinician reported
information was available on the patients’
ADHD subtype and pharmacological treatment.
The ADHD subtypes were IA (n = 54), HI
(n = 6) or Combined (n = 75). As the HI group
was very small, the HI group was analyzed
together with the Combined group for ease of
interpretation. Pharmacological treatment data
included whether the patients were on (n = 94)
or off (n = 36) current pharmacological treat-
ment with methylphenidate (n = 69), amphetami-
nes (n = 12), atomoxetine (n = 3), or a
combination of these (n = 7). Three patients had
missing data on use of pharmacological treat-
ment. The patients on atomoxetine are included
in the group on current stimulant treatment in
this paper, as analyzing the data without these
patients did not alter the results. The differences
in distribution of sex and age between the
ADHD subtypes and between the stimulant
treatment groups were all non-significant. As no
interaction was found between medication use
and ADHD subtypes, we used the greatest sam-
ple sizes available when performing the respec-
tive analyses. All participants signed a written
informed consent, and the study was approved
by the Norwegian Regional Committee for Med-
ical and Health Research Ethics, RECWest (IRB
#3 (FWA00009490, IRB00001872)).
The Bergen Insomnia Scale
The Bergen Insomnia Scale (24) was constructed
based on the diagnostic criteria for insomnia
according to the Diagnostic and Statistical Manual
of Mental Disorders (DSM-IV) (1). It includes six
items rated on an 8-point scale, ranging from 0 to
7 days per week during the last month. The first
four assess sleep impairment (criteria A of the
DSM-IV) (has it taken you more than 30 min to
fall asleep after the light was switched off; have
you been awake for more than 30 min between
periods of sleep; have you awakened more than
30 min earlier than you wished without managing
to fall asleep again; have you felt that you have not
had enough rest after waking up). The last two
items refer to daytime sleepiness/tiredness that has
affected your participation at school or work, and
your dissatisfaction with sleep respectively (criteria
B). The criteria for a DSM-IV diagnosis of insom-
nia are fulfilled if a respondent reports ≥3 days per
week on at least one of the A-items and ≥3 days
per week on at least one B item. In addition, a total
composite score is calculated by adding together
the scores for each item, with a possible range of
0–42. The BIS thus provides both a dichotomous
score for the presence of insomnia and a dimen-
sional symptom score. The Cronbach’s alpha of
the BIS scale used in the present study was 0.86.
The Adult ADHD Self-Rating Scale
The Adult ADHD Self-Rating Scale (ASRS) is the
World Health Organization’s (WHO) official
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screener for ADHD, and consists of the 18 symp-
toms listed in the DSM-IV criteria A (25). Nine
items assess symptoms of inattention (ASRS-IA)
and nine items assess hyperactive/impulsive symp-
toms (ASRS-HI), respectively, rated on a scale
from 0 to 4 (0 = never, 1 = rarely, 2 = sometimes,
3 = often and 4 = very often), yielding a total
range of 0–72. The total scores on the two sub-
scales of IA and HI were used as continuous mea-
sures of the two main symptom domains of
ADHD. Cronbach’s alpha was 0.92 on the ASRS-
IA subscale and 0.92 on the ASRS-HI subscale.
Statistics and analytical plan
Data were analyzed using SPSS v-23 (26). Indepen-
dent samples t-tests were used to compare pairs of
groups on continuous variables and chi-square
tests for categorical variables. Logistic regression
analysis with insomnia (yes/no) as the output vari-
able was used to investigate the association
between self-reported current ADHD symptom
scores and the insomnia diagnosis. A final linear
regression model, with the BIS score as the output
variable, was included to investigate the associa-
tion between self-reported symptoms of inattention
and hyperactivity-impulsivity and the severity level
of insomnia symptoms. These two regression mod-
els were run separately for the ADHD and the con-
trol group. Adjusted models are controlled for age,
sex and self-reported comorbid anxiety/depression.
Significance levels were set at the 0.05 level on two-
tailed tests, unless otherwise indicated.
Results
The differences in mean age and sex distribution
between the ADHD patients and the controls were
non-significant (age range from 18 to 74 in the
ADHD sample and 19–73 in the controls, for more
details see Table 1). The BIS total sum score was
significantly higher in the ADHD group compared
to the control group (t (457.7) = 11.5, P <
0.001). In the clinician defined subgroups, the
Combined subtype had higher scores than the IA
subtype (t (131) = 2.1, P = 0.036). Furthermore,
ADHD patients currently using ADHD medica-
tion had lower insomnia scores than patients
without stimulant treatment (t (126) = !2.4, P =
0.017) (Table 2).
As shown in Table 2, the ADHD group had
higher scores on all six BIS items than the control
group. Overall, the prevalence of adults with
ADHD fulfilling the criteria for an insomnia diag-
nosis was 66.8%, which was significantly higher
than the prevalence of 28.8% in the control group
(v2 = 65.2, P < 0.001). The ADHD subtypes also
differed in prevalence of insomnia (v2 = 8.9,
P = 0.003), with the Combined subtype having a
higher prevalence of insomnia than the IA subtype
(79.7% and 55.6% respectively). There was no sig-
nificant difference in prevalence of insomnia
between the groups on and off stimulant treatment,
66.3% and 72.2% respectively) (Table 2). How-
ever, the treatment group reported a significantly
lower insomnia symptom score than the group not
currently on stimulant treatment.
As expected, the ADHD group had signifi-
cantly higher ASRS scores than the control
group (P < 0.001) (Table 3). Of note, the group
off medication reported higher ASRS scores than
the subgroup on current stimulant treatment on
both the ASRS-IA (t(87.4) = 3.7, P < 0.001) and
the ASRS-HI subscales (t(127) = 2.6, P = 0.011).
A logistic regression analysis showed that having
ADHD was associated with a five-fold increased
odds-ratio for insomnia in the full sample [OR:
5.0 (95% CI: 3.3–7.4)]. Further analyses included
the ASRS subscales as predictors (Table 4).
Logistic regression analysis showed that both
ASRS subscales were significantly associated
with insomnia in the full sample, but that only
ASRS-IA remained a significant predictor when
adjusting for sex, age and comorbid anxiety/de-
pression. Of note, the anxiety/depression variable
was dichotomous, whereas the ASRS consisted
of two scales. The odds of self-reported insom-
nia thus increased by 0.091 (OR = 1.091) per
increased score of ASRS-IA in the full sample.
When analyzed separately, anxiety/depression
was the only significant predictor of insomnia in
Table 1. Age and sex distributions in the control sample and the ADHD sample
Controls Total ADHD
ADHD Subtypes On current stimulant treatment









Age (SD) 36.5 (8.0) 38.1 (11.4) 33.2 (9.5) 35.9 (10.0) 34.1 (10.4) 36.7 (8.6)




the control sample, whereas ASRS-IA was the
only significant predictor in the ADHD sample.
The BIS sum score was included as an outcome
variable in a linear regression analysis (Table 5),
showing that 31% of its variance was explained by
the two ASRS-subscales in the full sample. Each
subscale contributed significantly, and they contin-
ued to do so even when controlled for sex, age and
comorbid anxiety/depression. When analyzed sep-
arately within the ADHD and control groups, sig-
nificant contribution was restricted to the ASRS-
HI subscale, with a somewhat stronger overall
explained variance in the ADHD group (16.1%)
than in the control group (9.7%). The ASRS-HI
scale remained significant in the adjusted models,
with sex and anxiety/depression as added
significant predictors in the control sample and
ASRS-IA and anxiety/depression as added signifi-
cant predictors in the ADHD sample.
Discussion
The present study showed that insomnia was far
more frequent among adults with ADHD (66.8%)
than in the population controls (28.8%), with the
highest prevalence in the Combined subtype
(79.7%). There was no significant difference in the
prevalence of insomnia between the ADHD sub-
groups on and off medication. The total BIS scores
of the un-medicated patients were, however, signif-
icantly higher than for patients receiving stimulant
treatment, as were the BIS scores of the Combined
compared to the IA subtype. Regression analyses
showed that the self-reported IA subscale of the
ASRS significantly contributed to explain an
insomnia diagnosis in the ADHD and the control
group, while both the ASRS-HI and ASRS-IA
subscales contributed significantly when the total
BIS score was used as an outcome variable.
Attention-deficit hyperactivity disorder and sleep
problems, including insomnia, are bi-directionally
related and mutually exacerbating conditions (9,
27). As ADHD is a heterogeneous developmental
disorder, there are likely to be variations in the rela-
tionship between ADHD and insomnia. We
explored this by examining differences in insomnia
for subtypes of ADHD as rated by the clinicians
referring the patients, and by including information
about self-reported ADHD symptoms. We found
that the ADHD Combined subtype had a higher
Table 2. Scores on the Bergen Insomnia Scale (BIS)














BIS1 Has it taken you more than 30 min to fall
asleep after the light was switched off?
1.4 (1.8) 3.4 (2.5)** 3.9 (2.4) 3.2 (2.6) 3.5 (2.5) 3.9 (2.4)
BIS2 Have you been awake for more than
30 min between periods of sleep?
1.0 (1.7) 2.2 (2.2)** 2.4 (2.4) 1.9 (2.1) 2.0 (2.2) 2.8 (2.3)
BIS3 Have you awakened more than 30 min
earlier than you wished without managing to fall asleep again?
0.8 (1.3) 2.2 (2.3)** 2.1 (2.5) 1.7 (1.9) 1.7 (2.1) 2.8 (2.4)*
BIS4 Have you felt that you have not had enough rest after waking up? 2.7 (2.0) 4.4 (2.3)** 4.9 (1.9) 4.0 (2.3)* 4.3 (2.1) 4.9 (2.3)
BIS5 Have you been so sleepy/tired that it has
affected you at school/work or in your private life?
1.0 (1.5) 2.5 (2.2)** 2.9 (2.1) 2.5 (2.1) 2.4 (2.0) 3.3 (2.1)*
BIS6 Have you been dissatisfied with your sleep? 1.9 (2.0) 3.7 (2.4)** 4.3 (2.1) 3.3 (2.4)* 3.6 (2.2) 4.5 (2.5)
BIS Sum (SD) 8.9 (7.4) 18.3 (10.1)** 20.6 (10.0) 16.8 (10.3)* 17.5 (9.5) 22.2 (10.6)*
BIS Insomnia (%) 28.8 66.8** 79.7 55.6** 66.3 72.2
*P < 0.05
**P < 0.01
Table 3. Scores on the Adult ADHD Self-Rating Scale (ASRS)
Controls Total ADHD
ADHD Subtypes On current stimulant treatment









ASRS SUM (SD) 21.5 (9.6) 42.7 (13.0)** 46.0 (12.0) 37.0 (13.9)** 40.2 (14.5) 47.8 (9.6)**
Inattention (SD) 11.8 (5.0) 22.5 (6.5)** 23.8 (6.2) 20.7 (7.5)** 21.1 (7.1) 25.4 (5.2)**
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prevalence of insomnia than the IA subtype. When
including information about symptom domains,
reported at the same time as the insomnia symp-
toms, inattention was found to be most closely asso-
ciated with a diagnosis of insomnia. Since the
inattention score was substantially higher in the
ADHD-Combined subtype than the other subtypes
(see Table 3), both findings support the interpreta-
tion that overall ADHD severity is a main predictor
of insomnia. Our findings thus support previous
reports of the severity of sleep problems being
positively related to the severity of ADHD
symptoms (17).
The finding that inattentive symptoms were
more strongly correlated to insomnia symptoms
in the control group than in the ADHD group,
suggests that a close association between inatten-
tive symptoms and insomnia is not restricted to
adults with an ADHD diagnosis. Without any
information about causal relationship, inattentive
symptoms may as likely be a consequence of sleep
problems than the other way around. It is well
known that in itself, insomnia may mimic and
cause symptoms resembling ADHD and may also
exacerbate underlying ADHD symptoms (7), cre-
ating a vicious cycle. This may be detrimental to,
Table 4. Odds Ratios for Insomnia for the different ASRS ADHD symptom domains
Predictor Crude OR 95% CI P Adjusted OR 95% CI P
Full sample
Inattention 1.092 1.045–1.140 <0.001 1.091 1.043–1.141 <0.001
Hyperactivity/Impulsivity 1.050 1.008–1.093 0.019 1.036 0.994–1.080 0.095
Sex 0.697 0.453–1.072 0.100
Age 0.982 0.962–1.003 0.096
Anxiety/Depression 1.858 1.179–2.929 0.008
Controls
Inattention 1.095 1.007–1.191 0.035 1.087 0.995–1.188 0.065
Hyperactivity/Impulsivity 1.036 0.963–1.116 0.341 1.032 0.956–1.113 0.420
Sex 0.558 0.271–1.149 0.114
Age 0.984 0.945–1.025 0.443
Anxiety/Depression 2.504 1.098–5.711 0.029
ADHD
Inattention 1.062 1.005–1.123 0.034 1.068 1.009–1.131 0.022
Hyperactivity/Impulsivity 1.044 0.993–1.097 0.091 1.033 0.982–1.088 0.208
Sex 0.732 0.417–1.284 0.277
Age 0.983 0.960–1.008 0.179
Anxiety/Depression 1.324 0.738–2.374 0.346
OR, Odds ratio; CI, Confidence interval. Adjusted ORs have been controlled for age, sex, and comorbid anxiety/depression.
Table 5. Multiple Regression analyses for the effect of ASRS ADHD symptom domains on the BIS sum score
Predictor
Crude Adjusted
B SE B b P 95% CI for B B SE B b P 95% CI for B
Full sample
Inattention 0.327 0.084 0.255 <0.001 0.163–0.491 0.291 0.083 0.227 0.001 0.127–0.454
Hyperactivity/Impulsivity 0.406 0.079 0.334 <0.001 0.250–0.562 0.338 0.079 0.278 <0.001 0.183–0.492
Sex 1.704 0.796 0.082 0.033 0.140–3.268
Age !0.061 0.039 !0.061 0.113 !0.137–0.014
Anxiety/Depression !3.672 0.880 !0.180 <0.001 !5.401 to !1.943
Model F: 103.949 AdjR2 0.310 F: 49.207 AdjR2 0.345
Controls
Inattention 0.230 0.134 0.156 0.087 !0.033 to 0.493 0.186 0.131 0.128 0.158 !0.072 to 0.443
Hyperactivity/Impulsivity 0.265 0.120 0.201 0.028 0.029–0.501 0.238 0.114 0.185 0.038 0.014–0.463
Sex 2.065 1.000 0.138 0.040 0.094–4.037
Age !0.112 0.060 !0.125 0.063 !0.229 to 0.006
Anxiety/Depression !3.578 1.337 !0.187 0.008 !6.215 to !0.941
Model F: 11.572 AdjR2 0.097 F: 8.009 AdjR2 0.152
ADHD
Inattention 0.229 0.119 0.148 0.056 !0.006 to 0.464 0.237 0.119 0.153 0.047 0.003–0.471
Hyperactivity/Impulsivity 0.411 0.107 0.295 <0.001 0.200–0.622 0.350 0.108 0.251 0.001 0.136–0.563
Sex 1.598 1.194 0.078 0.182 !0.754 to 3.949
Age !0.036 0.051 !0.040 0.480 !0.136 to 0.064
Anxiety/Depression !2.923 1.242 !0.137 0.019 !5.368 to !0.478
Model F: 25.910 AdjR2 0.161 F: 12.246 AdjR2 0.178
B, Beta; SE, Standard Error; b, Standardized Beta; CI, Confidence interval; AdjR2, Adjusted R2. Adjusted models have been controlled for age, sex, and comorbid anxiety/depression.
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for example, learning outcomes, both through
lack of attentional resources and through lack of
consolidation through sleep (10). The bidirection-
ality of this relationship indicates that adequate
treatment of ADHD may also be important in
improving insomnia. One may be hesitant to use
stimulant medication late in the afternoon/evening
as insomnia has been associated with stimulant
treatment. Our findings however do not support
the advice to abstain from medication for fear of
causing or exacerbate insomnia in ADHD. The
prevalence of insomnia was so high that it should
rather be viewed as a problem intrinsic to ADHD.
Second, we found no support of an exacerbating
effect of stimulant treatment. In fact, and in line
with studies suggesting a beneficial effect of
ADHD medication in adults with ADHD (21,
23), we found that adult ADHD patients who
were currently on stimulant treatment obtained a
lower BIS sum score compared to those who were
not on stimulant treatment, although the preva-
lence of insomnia was similar across the two
groups. Generally, our findings fit well with and
extend previous studies on ADHD and insomnia
in children and adolescents (28, 29). According to
the present knowledge and the present study, the
best clinical practice seems to be active pharmaco-
logical management of ADHD, combined with a
close monitoring of sleep problems in all patients
with ADHD regardless of medication. The high
overall prevalence of insomnia in ADHD found
in the present study, and indications that ADHD
patients with the most severe symptoms are also
the ones with the most severe insomnia, make it
imperative to provide adequate treatment target-
ing insomnia in the clinical management of
ADHD, alongside other problems associated with
ADHD symptoms (30, 31). If insomnia is
detected, it should be specifically targeted in addi-
tion to the ADHD itself, but not preclude stimu-
lant treatment.
Limitations
This study employed a cross-sectional, survey
design, limiting the possibility of making causal
conclusions. Our definition of insomnia may be
inadequate to differentiate patients suffering from
delayed sleep phase disorder (DSPD), which is
not easily distinguishable from sleep-onset insom-
nia (32). The use of stimulant treatment was clin-
ician reported, not based on, for example, blood
samples, thus not objectively measured. Particu-
larly in the ADHD group, a large fraction of the
participants reported present and/or life-time
occurring comorbid conditions, such as anxiety/
depression, bipolar disorder, dyslexia or sub-
stance use disorders (Table S1) (33). While no
formal exclusion criteria were used to ensure
more clinically valid phenotypes, such comorbidi-
ties may have added to the general symptom
load, and also influenced the associations with
insomnia. The design of the present study pre-
cludes strong conclusions, as insomnia as a side-
effect from medication may be the cause for ces-
sation. Further studies with experimental designs
are needed to clarify this association. One way to
assess the relationship between sleep problems
and ADHD would be to systematically screen
for insomnia before starting stimulant treatment
of ADHD, thus enabling the clinical evaluation
of insomnia symptoms associated with stimulant
treatment (21).
Strengths of the study include the use of a large,
clinically validated sample of adult ADHD
patients and representative population controls, as
well as validated screening tools for insomnia and
ADHD symptoms. The BIS has high external and
internal validity and worked well in the present
study. Its brevity and free availability thus makes
it well suited to screen for and detect insomnia in
ADHD patients in clinical practice.
To conclude, insomnia is an important health
problem that needs to be addressed in adult
ADHD patients. Compared to population-based
controls, ADHD patients had a five-fold increased
odds ratio of having insomnia. Patients with the
Combined subtype of ADHD reported a signifi-
cantly higher prevalence of insomnia than the Inat-
tentive subtype. Patients currently using ADHD
medication reported significantly lower insomnia
scores than patients not using ADHD medication.
Our results indicate that stimulant treatment of
ADHD, as used in practice and over time, is not
associated with worsening of the severe difficulties
with insomnia that are found to be a commonly
associated condition of ADHD.
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Neuropsychiatric Genetics
Aggressiveness is a behavioral trait that has the potential to be
harmful to individuals and society. With an estimated herita-
bility of about 40%, genetics is important in its development.We
performed an exploratory genome-wide association (GWA)
analysis of childhood aggressiveness in attention deficit hyper-
activity disorder (ADHD) to gain insight into the underlying
biological processes associated with this trait. Our primary
sample consisted of 1,060 adult ADHD patients (aADHD). To
further explore the genetic architecture of childhood aggres-
siveness, we performed enrichment analyses of suggestive
genome-wide associations observed in aADHD among GWA
signals of dimensions of oppositionality (defiant/vindictive
and irritable dimensions) in childhood ADHD (cADHD).
No single polymorphism reached genome-wide significance
(P< 5.00E-08). The strongest signal in aADHD was observed
at rs10826548,within a longnoncodingRNAgene (beta¼#1.66,
standard error (SE)¼ 0.34, P¼ 1.07E-06), closely followed by
rs35974940 in the neurotrimin gene (beta¼ 3.23, SE¼ 0.67,
P¼ 1.26E-06). The top GWA SNPs observed in aADHD showed
significant enrichment of signals from both the defiant/vindic-
tive dimension (Fisher’s P-value¼ 2.28E-06) and the irritable
dimension in cADHD (Fisher’s P-value¼ 0.0061). In sum, our
results identify a number of biologically interesting markers
possibly underlying childhood aggressiveness and provide tar-
gets for further genetic exploration of aggressiveness across
psychiatric disorders. ! 2016 Wiley Periodicals, Inc.
Key words: ADHD; aggression; GWAS
INTRODUCTION
Aggressiveness can be defined as any behavior directed toward an
individual with the immediate intent to cause harm [Anderson and
Bushman, 2002]. Violence, which is strongly related to aggres-
siveness, is the sixth leading cause of burden of disease for people
aged 15–44 years worldwide [WHO, 2008]. To date, most inter-
ventions designed to reduce violence risk typically have small effects,
reflecting our limited understanding of its causes and stressing the
need for further studies [Moffitt, 2005; McGuire, 2008].
As a complex phenomenon, aggressiveness spans across numer-
ous facets of human behavior, ranging from emotional lability and
temperamental traits (e.g., hot-tempered, short fuse, irritable) to
physical violence [Lesch et al., 2012]. These traits are frequently
found among youth with attention deficit hyperactivity disorder
(ADHD), a common child and adolescent psychiatric disorder
with a prevalence of about 5% and a rate of persistence into
adulthood of about 50% [Faraone et al., 2015]. ADHD is defined
by symptoms of inattention and hyperactivity/impulsivity, and
youth with ADHD often have co-existing disorders, some of which
are closely related to aggressiveness and violence, such as conduct
disorder (CD) and/or oppositional defiant disorder (ODD) and
disorders characterized by symptoms defined within the broader
term of antisocial behavior [Dalsgaard et al., 2002]. These disorders
put youth with ADHD at high risk of problems associated with
aggressiveness in adulthood [Klassen et al., 2010], especially when
the aggressive behavior has an early onset [Hofvander et al., 2009].
This can be illustrated by the fact that around 30% of youth and
25% of adult prison inmates are found to qualify for an ADHD
diagnosis [Young et al., 2014]. Studies of childhood aggressiveness
in adults can, therefore, be of great importance to improve our
understanding of adult ADHD.
The etiology of ADHD as well as traits of aggressiveness is
complex, with genetics playing an important role. The heritability
of ADHD has been estimated to be up to 88% across the lifespan
[Larsson et al., 2013], whereas the estimates of genetic influence on
aggression vary across studies, collectively reaching about 40–50%
[Brendgen et al., 2006; Tuvblad and Baker, 2011]. Such diversity in
the estimation of aggression heritability may result from inconsis-
tency in measures across studies. Several different aggression
measures have been utilized to assess the genetic and environmen-
tal influences on its development [Veroude et al., 2015], reflecting
that there is no consensus regarding its definition [Ramirez and
Andreu, 2006]. Furthermore, the estimates of aggressiveness are
influenced by the age of the study participants. The literature
reports stability of aggressiveness between childhood and adult-
hood, with adolescence as a transient period with little stability in
this trait [Moffitt, 2005]. Genes seem to explain little variation in
adolescent aggression, but are likely to account for individual
differences in childhood and adult aggression [Lyons et al.,
1995]. Also, given higher levels of aggression in males and higher
genetic load inmales with antisocial behavior compared to females,
it is an open question whether genetic propensity is of greater
importance in one sex over the other [Miles and Carey, 1997;
Tuvblad and Baker, 2011]. Interestingly, similar considerations of
age and sex effects are also present in studies of ADHD as well as
when ADHD is co-morbid with aggressive behavior [Faraone
et al., 1991, 2015].
Given that ADHD and aggression often co-occur and that both
traits are heritable, twin studies have noted the possibility of shared
genetic etiology between ADHD and aggression. A common
genetic factor has been reported among ADHD and symptoms
of aggression in 9–10-year-old children [Tuvblad et al., 2009].
Likewise, it has been suggested that impulsivity and aggression are
genetically mediated to a similar extent [Seroczynski et al., 1999].
Influenced by major theories on neuronal circuits, genetic
association studies of ADHD and/or aggression have been domi-
nated by candidate gene studies, focusing on the regulation of
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monoaminergic transmission [Faraone et al., 2015; Veroude et al.,
2015]. In line with twin studies, these candidate gene analyses have
provided further support toward a shared genetic component
between ADHD and aggression. Many genes associated with
ADHD point toward the same biological mechanisms as those
associated with aggressive behavior, including genes that are
involved in the synthesis, binding, transport and degradation of
neurotransmitters, especially dopamine and serotonin [Faraone
et al., 2015; Veroude et al., 2015]. It has been reported, for example,
that the genesMAOA, DRD2, DRD4, COMT, SLC6A4, TPH1, and
TPH2 may contribute to the development of ADHD as well as
aggressive behaviors [Gizer et al., 2009; Vassos et al., 2014].
However, these candidate gene studies suffer from the lack of
replication in independent samples (where available) and small
effect sizes suggest that some of these genes play amore limited role
in the susceptibility to ADHD and/or aggressive behavior, or that
their involvement may be limited to rare familial cases [McKinney
et al., 2008; Halmoy et al., 2010; Tiihonen et al., 2014]. Thus, the
overall genetic architecture of ADHD and/or aggression remains
largely unknown and warrants studies using a hypothesis-free
approach [Vassos et al., 2014].
Genome-wide association (GWA) studies allow interrogation
of the entire genome to generate new hypotheses. To date, few
GWA studies have been performed for ADHD and/or aggres-
siveness, with no finding passing the stringent Bonferroni-
corrected genome-wide significance level (P< 5.00E-08) for
either phenotype [Dick et al., 2011; Tielbeek et al., 2012; Mick
et al., 2014; Salvatore et al., 2015]. Nonetheless, as these studies
were generally underpowered, some understanding of biological
processes behind ADHD and/or aggressiveness may emerge from
the convergence of identified nominally significant loci. Previous
GWA studies on aggressive behaviors in ADHD have noted a
number of suggestive association signals, generating biological
hypotheses regarding the etiology of ADHD and/or aggression
[Anney et al., 2008; Aebi et al., 2015]. In addition, a recent GWA
study revealed a positive linear correlation between ADHD
polygenic scores and comorbid aggression scores, indicating
that the presence of aggressive symptoms in ADHD is likely to
index a greater genetic load [Hamshere et al., 2013]. Similarly
hypothesis-free, genome-wide linkage analyses have also reported
evidence of significant co-segregation between ADHD and dis-
ruptive behavior [Jain et al., 2007].
The lack of robust genetic association signals may be explained
by the modest sample sizes and the complex nature of both
ADHD and aggressiveness, where genetic factors are intertwined
with environmental influences [Brendgen et al., 2006]. In addi-
tion, heterogeneity in genetic susceptibility, phenotypic manifes-
tation, and operationalization of aggressiveness may depress
association signals [Cross-Disorder Group of the Psychiatric
Genomics et al., 2013]. The phenotypic heterogeneity in
ADHD may potentially be exacerbated by its high rates of
comorbidity with not only aggressive behaviors, but also
mood and anxiety disorders [Biederman et al., 1992]. Another
possible reason behind the lack of replicable genetic findings is
the limited annotation of the human genome. The annotation
has mostly been focused on protein-coding genes that represent
only $1% of our genome, making it difficult to evaluate possible
biological pathways involved in ADHD and/or aggressiveness, as
the majority of GWA findings tend to reside outside the tradi-
tional protein-coding regions [Dick et al., 2011; Schizophrenia
Working Group of the Psychiatric Genomics, 2014].
In the present study, we aimed to perform exploratory genome-
wide association tests to shed light on the genetic susceptibility loci
and biological processes possibly involved in the etiology of
childhood aggressiveness in ADHD.We utilized the GWAmethod
to analyze childhood aggressiveness in adults with ADHD gathered
in studies across Europe. To minimize phenotypic heterogeneity
between samples, we derived our measure of childhood aggres-
siveness in adult ADHD (aADHD) from the Wender Utah Rating
Scale (WURS). This questionnaire was used as part of the assess-
ment procedure at all sites. As the WURS reflects childhood
recollections, we also explored a possible genetic overlap of associ-
ation signals observed in aADHD with those of irritable and
defiant/vindictive dimensions of ODD in youth with ADHD
(cADHD) [Aebi et al., 2015]. Finally, we performed an examina-
tion of non-protein coding genes in order to obtain a better




aADHD samples. Recruitment of adult ADHD patients
was conducted at three sites within an international multi-
center persistent ADHD collaboration (IMpACT, http://www.
impactadhdgenomics.com): Germany, Norway, and Spain. All
individuals were of Caucasian ancestry. Only participants who
gave written informed consent were enrolled in the studies, which
complied with the Declaration of Helsinki.
German sample. Patients with a diagnosis of aADHD were
recruited by experienced psychiatrists at the University of
W€urzburg (W€urzburg, Germany). Unrelated in- and outpatients
of self-reported central-European descent completed a semi-
structured clinical interview according to DSM-IV. Inclusion
criteria were onset before the age of 7 years, lifelong persistence,
current diagnosis and age of recruitment between 18 and 65 years.
Exclusion criteria were the appearance of symptoms restricted to
the duration of any otherAxis I disorder; current diagnosis of active
alcohol or other drug abuse or dependence; lifetime diagnosis of
bipolar I disorder, schizophrenia, or any other psychotic disorder;
and an IQ score below 80. For a more detailed sample description,
please confer previous publications [Reif et al., 2009; Franke et al.,
2010]. The study was approved by the Ethic Committee of the
University of W€urzburg (W€urzburg, Germany).
Norwegian sample. Participants were recruited at the Univer-
sity of Bergen (UiB, Bergen, Norway) as described elsewhere
[Halmoy et al., 2009]. In short, adult patients with ADHD were
recruited through a Norwegian national medical registry as well as
by psychologists and psychiatrists working at outpatient clinics. All
patients had been previously diagnosed with ADHD using either
DSM-IV or ICD-10. The ICD-10 criteria were adapted to theDSM-
IV criteria by allowing the inattentive subtype as sufficient for the
ADHD diagnosis. Individuals with other neuropsychiatric disor-
ders were not excluded as long as the ADHD criteria were fulfilled.
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Individuals with IQ below 70 were excluded from the study. All
participants provided either blood or saliva samples for DNA
extraction. The study was approved by the regional committee
for medical and health research ethics, western Norway.
Spanish sample. Participants were recruited at the Depart-
ment of Psychiatry from the Hospital Universitari Vall d’Hebron
(HUVH, Barcelona, Spain) as described elsewhere [Sanchez-Mora
et al., 2015]. Patients were adults of Caucasian origin and met
Diagnostic and Statistical Manual for Mental Disorders-IV (DSM-
IV) criteria for ADHD. The diagnosis of ADHDwas evaluated with
the Structured Clinical Interview for DSM-IV Axis I and II Dis-
orders (SCID-I and SCID-II) and the Conner’s Adult ADHD
Diagnostic Interview for DSM-IV (CAADID Parts I and II).
Consensus eligibility criteria for the current study were a diagnosis
of ADHD according to the diagnostic criteria of DSM-IV, onset
before the age of 7 years via retrospective diagnosis (which was
confirmed by a family member, wherever possible), lifelong per-
sistence and current diagnosis. DNA was extracted from either
peripheral blood or saliva samples. The study was approved by the
ethics committee of the institution.
cADHD sample. Youth with ADHD were participants in the
International Multicentre ADHD Genetics (IMAGE) study,
recruited in 12 children and adolescent psychiatry clinics repre-
senting eight countries across Europe. Approval was obtained by
the Institutional Review Board of SUNY Upstate Medical Univer-
sity and from ethical review boards within each country. A detailed
description of the study design and assessment procedures has been
provided in previous publications [Muller et al., 2011a,b]. In short,
entry criteria for probands were a clinical diagnosis of ADHD
according to DSM-IV-based structured interviews and access to
one or both biological parents and one or more full siblings for
DNAcollection and clinical assessment. Exclusion criteria included
autism, epilepsy, IQ< 70, brain disorders, and any genetic or
medical disorder associated with externalizing behaviors that
might mimic ADHD.
Measures of Aggressiveness
aADHD samples. The adult measure of childhood aggres-
siveness in the aADHD samples was derived from the Wender
Utah Rating Scale (WURS) [Ward et al., 1993]. The WURS is a
questionnaire used for retrospective assessment of childhood
symptoms of ADHD in adults. An exploratory factor analysis
(EFA) was run to determine the latent structure of the WURS.
The EFA consisted of a principal component analysis with Varimax
rotation and yielded three factors with Eigen values above one.
From themain factor explaining the greatest amount of variance in
responses to the WURS (30.7%), the top six items with the highest
loadings (0.74–0.82) all represented prototypical elements of
aggressiveness: “temper outburst/tantrums,” “angry,” “hot- or
short-tempered/low boiling point,” “disobedient with parents/
rebellious/sassy,” “losing control of myself,” and “irritable,” For
each item, the participant was asked to evaluate if she/he as a child
was (or had) a specific symptom and to rate it according to the
following four response categories: “not at all/very slightly” (0),
“mildly” (1), “moderately” (2), quite a bit” (3), or “verymuch” (4).
The arithmetic sum of the responses of the aforementioned items
was adopted as a continuous measure of aggressiveness, ranging
from 0 to 24. Supplementary Figure S1 shows the distribution of
this measure across genders in the three aADHD datasets.
cADHD sample. The dimensions of oppositionality were
assessed using the long form of the revised Conners Parent Rating
Scale (CPRS-R:L) [Conners et al., 1998]. The defiant/vindictive
and irritable dimensions of ODD were defined on theoretical
grounds as described elsewhere [Aebi et al., 2015], and reflect
two previously described dimensions of ODD [Stringaris et al.,
2012; Aebi et al., 2013].
Genotype Data
Genotyping of each sample was performed by each of the four
participating groups, individually. To maximize available genetic
information among examined datasets, genetic imputation was
carried out independently at each site.
aADHD Samples
German sample. Genotyping of participants was performed
on Illumina’s PsychChip array (Illumina, San Diego, CA) at the
Broad Institute (Cambridge,MA) using the PsychChip 15048346 B
manifest. Genotypes were assigned in Illumina’s GenomeStudio
v2010.3, using the calling algorithm/genotyping module version
1.8.4. Quality control procedures were performed as described
previously, with lightly modified exclusion criteria (SNPs exhibit-
ing missingness above 98%; minor allele frequency below 5%;
failingHardy–Weinberg equilibrium test [P< 10#4]) [Zayats et al.,
2015]. Genotype imputation was performed with SHAPEIT/
IMPUTE2 pipeline as described elsewhere, using 1000 Genomes
Phase 3 data as a reference [Marchini et al., 2007;Howie et al., 2009;
Cross-Disorder Group of the Psychiatric Genomics, 2013].
Norwegian sample. Participants were genotyped on Human
OmniExpress-12v1-1_B (Illumina, San Diego, CA) platform at the
deCODE Genetics facility (Reykjavik, Iceland). Genotyping and
quality control procedures are described elsewhere [Zayats et al.,
2015]. Imputation was performed utilizing IMPUTE software as
previously detailed [Marchini et al., 2007;Howie et al., 2009; Cross-
Disorder Group of the Psychiatric Genomics, 2013].
Spanish sample. Genome-wide genotyping was performed
with the Illumina HumanOmni1-Quad BeadChip platform. Qual-
ity control was implemented at the individual and SNP level using
PLINK and included filtering subjects with low call rate (<98%) or
gender discrepancy followed by filtering SNPs with minor allele
frequency (MAF)< 0.01, Hardy–Weinberg equilibrium test
P-values< 1e-06 or call rate< 0.99 in either cases or controls.
Imputation was performed using BEAGLE software [Browning
and Browning, 2007].
cADHD sample. Sample collection and DNA isolation has
been described previously [Brookes et al., 2006]. Genome-wide
genotyping and quality control was performed as part of the GAIN
study using the Perlegen 600K genotyping platform, as previously
described [Neale et al., 2008]. The imputationwas performed using
MACH and the Hapmap 2 (Release 22 Build 36) reference data set
[Li et al., 2010]. Quality control was performed on the imputed
data, and SNPs with imputation quality scores lower than 0.30, a
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minor allele frequency lower than 0.01, and those failing the
Hardy–Weinberg equilibrium test at a threshold of P% 10#5
were excluded. SNPs and subjects with missingness rates higher
than 0.05 were removed from the data.
Statistical Analyses
The age and gender distributions between the aADHDand cADHD
samples were assessed using x2 for gender and ANOVA for age.
Genome-wide association (GWA) of aggressiveness. In the
aADHD sample, single nucleotide polymorphisms (SNPs) were
tested for association with the WURS-derived measure of aggres-
siveness in the form of linear regression carried out in PLINK using
post-imputation dosage data [Purcell et al., 2007]. Regression
models were adjusted for age and sex. Genotype data of each site
were first processed individually. The results were then combined
with the use of fixed-effects inverse variance meta-analysis in
METAL [Willer et al., 2010]. Only SNPswithminor allele frequency
(MAF)equal toor above1%and imputation INFOmeasure equal to
or above 0.6 were included in the analyses. Genomic control, QQ
plotting, and regional plotting of top loci were applied to check the
integrity of test statistics [Devlin and Roeder, 1999; Cuellar-Partida
et al., 2015]. The genomic inflation factor was calculated using
METAL [Willer et al., 2010]. A genome-wide significance threshold
of 5.00E-08 was adopted to correct for multiple testing.
GWA analyses of irritable and defiant/vindictive dimensions of
ODD in cADHD sample was performed in PLINK software in the
form of linear regression adjusted for sex and age [Purcell
et al., 2007]. Details of the analyses are described elsewhere
[Aebi et al., 2015].
Gene-based and Gene-set association of aggressiveness in the
aADHD meta-analyzed sample. Gene-based and gene-set path-
way analysis were performed in the aADHD sample carried out in
MAGMA software [de Leeuw et al., 2015]. First, a degree of
association was calculated for each gene based on METAL-derived
individual SNPs’ P-values, using 1000 Genomes CEU dataset as a
reference panel to correct for linkage disequilibrium (LD)
[Genomes Project et al., 2012]. To evaluate each gene’s contribu-
tion to examined gene-sets (gene-set pathway analysis), the P-value
of each gene was converted to a Z-value and used as an outcome
variable in a regression model with gene-set membership as a
predictor. Gene size and gene-sets’ gene density were added as
covariates to adjust for possible confounding effects and prevent
spurious association.
For gene-based tests, we assessed the association with both
protein and non-protein-coding genes. The protein-coding gene
list was curated from the catalog of known genes downloaded from
the Genome Browser of the University of California Santa Cruz
(UCSC, CA). The non-protein-coding genes were examined in the
form of long non-coding RNA (lncRNA) genes detailed in the
aforementioned catalog. For gene-set pathway analysis, we exam-
ined structural categories of gene ontology (GO, http://
geneontology.org), with respect to cellular function, biological
process and cellular compartments. To achieve meaningful statis-
tics and interpretation of the results, we restricted our pathway
analysis to those GO terms that contained SNPs in at least 10 genes
per term in our aADHD data.
Genome-wide enrichment analyses between GWA results in
aADHD and cADHD samples. Prior to performing enrichment
analyses, the genetic data in both aADHD and cADHD samples
were pruned to remove correlated loci in linkage disequilibrium
(LD) with each other. A pairwise correlation coefficient (r2)
threshold of 0.2 and the 1000 Genomes CEU reference dataset
were used to identify independent SNPs, as previously described
[Lindgren et al., 2009; Genomes Project et al., 2012].
Enrichment was examined by means of Fisher’s test performed
in the R software, assessing the difference in proportion of
SNPs revealing association P-values below 0.05 in the cADHD
sample according to suggestive association in the aADHD sample
(P-value belowor equal to 1.00E-03 versusP-value above 1.00E-03)
[Rahmioglu et al., 2015]. Consistency in directionality of SNP
effects with indication of enrichment between aADHD and
cADHD samples was tested as linear regression on the effect
(beta) of each SNP for aADHD as an outcome and for cADHD
(either irritable or defiant/vindictive dimensions of ODD, respec-
tively) as predictor variables [Do et al., 2013].
Examination of previously reported aggressiveness-related
candidate GWA loci. We assembled a list of previously reported
candidate GWA loci associated with aggressive behavior by
systematic literature search the catalog of published genome-
wide association studies provided by National Human Genome
Research Institute (NHGRI) (https://www.genome.gov/26525384),
using key words of “aggression,” “anger,” “violence,” as well as
“conduct disorder” and “antisocial personality disorder.” Each
identified candidate GWA locus was then looked up in meta-
analyzed aADHD sample.
RESULTS
Subjects, Measure of Aggressiveness, and
GWA Analyses
In total, 1,060adultpatientsaswell as750childrenandadolescentswith
ADHD were available for the analyses. The age ranges in the aADHD
samples were 17–75 in the German sample, 18–57 in the Norwegian
sample, and 17–60 in the Spanish sample. In the cADHD sample, the
age range was 5–17. Details of the final samples are summarized in
Table I. Supplementary Figure S1 presents the distribution of the
selected measure of aggressiveness in each aADHD dataset.
After quality control of imputed SNPs in the adult samples,
9.301.568 SNPs were available for the analyses in the German
sample, 8.910.491 SNPs in the Norwegian sample, and 6.683.176
SNPs in the Spanish sample. Among these three datasets, 7.576.458
autosomal SNPs were present in at least two and, thus, were meta-
analyzed to assess genetic architecture of childhood aggressiveness
in aADHD. In cADHD sample, 1.871.025 autosomal SNPs were
available for the analyses.
IndividualGWAanalyses revealednogenome-wide significanthits
(P% 5.00E-08) in either aADHD sample (not shown) nor in the
cADHD sample (Supplementary Table SI and Fig. S2). None of the
variants in the meta-analysis reached the Bonferroni-corrected
genome-wide significance level (P% 5.00E-08) either. The strongest
signal was observed at rs10826548 on chromosome 10 located within
the transcript of a long noncoding RNA (lncRNA) (beta¼#1.66,
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standard error (SE)¼ 0.34, P-value¼ 1.07E-06) (Fig. 1), closely
followedby rs35974940 in the neurotrimin (NTM) gene (beta¼ 3.23,
SE¼ 0.67, P-value¼ 1.26E-06) (Fig. 2). Top associated markers
(P% 1.00E-05) are summarized in Supplementary Table SII. The
genomic inflation factor was close to one for all individual andmeta-
GWA analyses in aADHD.QQplots of GWA analyses in aADHD are
presented in Supplementary Figure S3.
Gene-Based and Gene-Set Association
of Aggressiveness in the aADHD
Meta-Analyzed Sample
Among annotated protein-coding genes, 17.595 hadmore than one
SNP present in the aADHDdata. The strongest signal was noted for
the WD repeat domain 62 (WDR62) gene (P-value¼ 4.84E-05).
Supplementary Table SIII summarizes the top protein-coding genes
(P% 1.00E-03) observed in aADHD sample. None of the protein-
coding gene-based tests survived the correction formultiple testing.
Among lncRNAgenes, 22.696 hadmore than one SNPpresent in
our aADHD data. The strongest association was observed for
ENST00000427806 (P-value¼ 3.04E-05). The top lncRNA genes
(P% 1.00E-03) detected in this study are reported in Supplemen-
tary Table SIV. None of the non-protein-coding gene-based tests
survived the correction for multiple testing.
Among GO pathways, 1.945 terms contained SNPs in at least 10
genes per term in the aADHDdata. Themost prominent association
wasobserved for negative regulationof I-kappaBkinase/NF-kappaB
signaling pathway (GO:0043124 term, P-value¼ 7.26E-04). Sup-
plementary Table SV reports topGO terms (P% 0.01) recognized in
this study. None of the GO pathways survived the correction for
multiple testing.
Genome-Wide Enrichment Analyses Between
GWA Results in aADHD and cADHD Samples
To assess potential genome-wide overlap of association signals
between measures of childhood aggressiveness in aADHD and
cADHD, we investigated the independent (r2< 0.2) GWA sig-
nals of suggestive significance (P% 1.00E-03) in aADHD for
enrichment in GWA signals of either defiant/vindictive or
irritable dimensions in cADHD. Given our modest sample
size, only those SNPs were considered in cADHD results that
revealed a P-value below or equal to 0.05 to avoid the examina-
tion of effects with a wide confidence interval. The top GWA
SNPs of WURS-derived childhood aggressiveness in aADHD
showed significant enrichment of signals from both the
defiant/vindictive dimension (Fisher’s P-value¼ 2.28E-06) and
the irritable dimension in cADHD GWA analysis (Fisher’s
P-value¼ 0.0061; Fig. 3A).
Next, we examined the directionality of effects of variants with
association signals in both aADHD and cADHD samples (P% 1.00
E-03 in aADHD and P< 0.05 in cADHD). Significant correlation
between betas was observed in assessment of both oppositional
dimensions in cADHD and childhood aggressiveness in aADHD
(P¼ 0.0053 and 0.0045 for defiant/vindictive and irritable dimen-
sions respectively), but the direction of the relationship was nega-
tive (Fig. 3B andC). Supplementary Table SVII summarizes the top
hits (P% 1-00E-05) observed in GWA meta-analysis of childhood
aggressiveness in aADHD and their corresponding statistics
observed in cADHD.
Examination of Previously Reported
Aggressiveness-Related Candidate Genes
and GWA Loci
Among previously reported aggressiveness-related GWA loci,
several SNPs noted to be associated with anger, conduct disorder
and adult anti-social personality disorder revealed P-values
below 0.05 in our study (Supplementary Table SVIII). The
strongest signal in the GWA analysis of childhood aggressiveness
in aADHD among the aforementioned loci was observed for
rs4889240 in the PKD1L2 (polycystic kidney disease 1-like 2)
gene (beta¼#0.73, SE¼ 0.25, P-value¼ 0.0039), previously
TABLE I. Details of the ADHD Patient Samples
aADHD samples
IMpACT site Number of participants Females (%) Age (mean& SD) Aggressiveness score (mean& SD)
Germany 368 53.0 35.18& 10.53 11.33& 5.17
Norway 293 52.6 32.61& 11.00 12.10& 6.39
Spain 399 32.3 31.31& 12.39 10.19& 6.15
Total 1,060 45.1 33.01& 11.51 11.11& 5.94
cADHD sample
ODD scores (mean& SD)
Number of participants Femalesa (%) Ageb (mean& SD) Irritable Defiant/vindictive
IMAGE 750 12.3 10.67& 2.77 7.75& 3.06 8.95& 4.18
SD, standard deviation.
Aggressiveness score was derived from WURS in the aADHD sample. In the cADHD sample, dimensions of oppositionality (irritable and defiant/vindictive dimensions) were examined [Aebi et al., 2015].
aDifference in the proportion of females between the aADHD and cADHD samples: P< 2.2E-16 (x2 test).
bDifference in age between the aADHD and cADHD samples: P< 2.2E-16 (ANOVA).
6 AMERICAN JOURNAL OF MEDICAL GENETICS PART B
reported to be associated with CD symptom count in ADHD
patients. The same SNP also revealed nominally significant
association in the same direction with the defiant/vindictive
dimension (beta¼#0.54, SE¼ 0.21, P-value¼ 0.0094), but not
with the irritable dimension in cADHD. In this result, one should
keep in mind that the cADHD described here is a subsample of
the sample in which the original finding for rs4889240 was
described [Aebi et al., 2015]. Full results of our literature search
are presented in Supplementary Table SVIII.
DISCUSSION
In this study, we performed a genome-wide exploration of child-
hood aggressiveness as reported retrospectively by adult patients
with ADHD (aADHD), examining both conventional protein-
coding and lncRNA genes. We also explored the overlap with
parent-reported oppositional behavior in youth with ADHD
(cADHD) and evaluated previously reported aggression-related
GWA loci. Given our modest sample size (1060 aADHD patients)
FIG. 1. Plot of the locus surrounding rs10826548. SNPs are plotted by position on chromosome 10 against GWA P-values for aggressive
behavior measure in aADHD. Estimated recombination rates from HapMap are plotted in bright red to reflect local LD structure. The SNPs
surrounding rs10826548 are color-coded to reflect their LD with it (according to pair-wise r2 values from the HapMap CEU database). SNPs
with LD r2' 0.2 are plotted at the bottom of the graph with LD color-coding specified in the top right corner. “Genes” refers to protein-coding
genes in the presented region. “lincRNAsAllCellTypeTopView” reflects the data from lncRNA USCS track in brain tissue. “tfbsConsSites” reflects
the TFBS UCSC track. [Color figure can be seen in the online version of this article, available at http://wileyonlinelibrary.com/journal/ajmgb].
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and the anticipated small effect of common polymorphisms in
complex traits, it is not surprising that we did not observe any
genome-wide significant SNPs (P< 5.00E-08). Nonetheless, we
were able to identify several nominally significant variants
(P% 1.00E-05) in biologically interesting genes for follow-up
studies of aggressiveness in ADHD, a feature of the disorder
that has received little attention so far.
The strongest signal in the performed single-point GWA tests
of childhood aggressiveness in aADHD was noted for rs10826548
(beta¼#1.16, SE¼ 0.34, P¼ 1.07E-06, Supplementary
Table SI). This variant resides in the transcript of a lncRNA
with uncertain coding potential (TCONS_00018147) (Fig. 1).
Non-protein coding RNAs play a critical role in the regulation of
gene expression and have been previously associated with neu-
ropsychiatric disorders, including ADHD [Perkins et al., 2005;
Gonzalez-Giraldo et al., 2015; Zayats et al., 2015]. In addition, it
has recently been observed that SNPs previously associated
with neurological and psychiatric conditions may be highly
FIG. 2. Plot of the locus surrounding rs35974940. SNPs are plotted by position on chromosome 11 against GWA P-values for aggressive
behavior measure in aADHD. Estimated recombination rates from HapMap are plotted in bright red to reflect local LD structure. The SNPs
surrounding rs35974940 are color-coded to reflect their LD with it (according to pair-wise r2 values from the HapMap CEU database). SNPs
with LD r2' 0.2 are plotted at the bottom of the graph with LD color-coding specified in the top right corner. “Genes” refers to protein-coding
genes in the presented region. “lincRNAsAllCellTypeTopView” reflects the data from lncRNA USCS track in brain tissue. “tfbsConsSites” reflects
the TFBS UCSC track. [Color figure can be seen in the online version of this article, available at http://wileyonlinelibrary.com/journal/ajmgb].
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concentrated in the regions of long non-protein coding RNA
genes [Ning et al., 2014].
The second most significant locus identified in this study is
located within the neurotrimin (NTM) gene (intronic rs35974940,
P¼ 1.26E-06, Supplementary Table SI and Fig. S2). NTM is a
protein-coding gene, encoding a member of glycosylphosphatidy-
linositol (GPI)-anchored cell adhesion molecules, containing
immunoglobulin (Ig) domain. These proteins are predominantly
expressed in the central nervous system (CNS) [Struyk et al., 1995].
Among the association signals observed in NTM gene, several
have the potential to alter its expression. As determined in
the TRANSFAC database implemented in the SNPinfo server
of the National Institute of Environmental Health Sciences
(http://snpinfo.niehs.nih.gov), rs34588147 and rs35665773 (GWA
P-values of 3.59E-06 and 3.25E-06, respectively, Supplementary
Table SI) are transcription factor binding sites (TFBS) (Fig. 2).
Moreover, two other SNPs in high linkage disequilibrium with the
aforementioned ones (rs12804059 and rs7119590, r2¼ 1 in CEU
population) also represent TFBS. Notably, differential expression
of NTM between two major brain regions linked to aggression
subtypes—prefrontal cortex and amygdala—was observed in
early prenatal stage of human brain development (P¼ 0.015,
http://www.brainspan.org).
Gene expression regulationduringneuronal development as one of
thepossiblemechanismsbehindaggressiveness in aADHDwas further
affirmed by our top associated lncRNA gene—ENST00000427806
(P¼ 3.04E-05, Supplementary Table SIV). The target gene of
this lncRNA has been predicted to be the protein-coding ST6
FIG. 3. Enrichment and direction of effect among GWA signals of oppositional dimensions in cADHD and WURS-derived childhood
aggressiveness in aADHD. Part A reflects the proportion of SNPs nominally associated (P< 0.05) with each examined oppositional dimension
in cADHD (defiant/vindictive and irritable) among suggestive signals (P% 1.00E-03) of association with childhood aggressiveness in aADHD.
Reported P-values are those of Fisher’s exact test. Parts B and C reflect directions of effect of 24 independent nominally significant loci in
GWA analyses of defiant/vindictive dimension in cADHD and childhood aggressiveness in aADHD (part B) as well as 17 independent nominally
significant loci in GWA analyses of irritable dimension in cADHD and childhood aggressiveness in aADHD (part C). Linear regression r2
measures and P-values are shown.
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(alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalac-
tosaminide alpha-2,6-sialyltransferase 5 (ST6GALNAC5) gene
[Vucicevic et al., 2015]. The protein encoded by ST6GALNAC5 is a
member of sialyltransferases, with reported function in cell adhesion
through cell–cell and cell–extracellular matrix interactions [Tsuchida
et al., 2003]. Intriguingly, ST6GALNAC5, similarly to NTM, also
revealed differential expression in the aggression-related structures
of prefrontal cortex and amygdala in early prenatal stages of human
brain development (P¼ 0.013; http://www.brainspan.org).
As the adult measure of aggressiveness was derived from self-
reported experiences in childhood, we examined the possibility of
overlap of its GWA signals with those from GWA analyses of two
oppositional dimensions in a cADHD sample.We observed a slight
enrichment of association signals between the nominally associated
loci in aADHD and those observed in the GWA of both the defiant/
vindictive and the irritable ODD dimensions examined in cADHD
(Fig. 3). However, it is noteworthy that the aADHD and cADHD
samples were imputed using different reference panels with dispa-
rate genomic coverage.
Surprisingly, the correlationbetween thedirectionof effectsof the
aforementioned SNPs was negative (Fig. 3B and C). Such an inverse
relationship in effect directionality between parent-reported ODD
dimensions and adult retrospective report of childhood aggres-
siveness is most likely a chance finding due to our study being
under-powered. It might also be related to phenotypic and genetic
heterogeneity of the examined samples. There were considerable
differences in thepercentage of females between the aADHDand the
cADHD samples (Table I), which could indicate such mechanisms.
It has been shown that both age and sex are important factors in
genetic influences inADHDandaggression [Lyons et al., 1995;Miles
and Carey, 1997; Tuvblad and Baker, 2011; Faraone et al., 2015]. In
addition, the aggressiveness in the cADHD sample was determined
by parent-report, whereas in the aADHD sample, it was based on
retrospective self-report. The correlationbetweenparent-report and
self-report has been shown to be generally poor [Achenbach et al.,
1987], as also discussed in a recent study that found little overlap
between samples of cADHD and aADHD [Moffitt et al., 2015].
Hence, the measures of aggressiveness in the cADHD and the
aADHD samples are different. Furthermore, the youth and adult
ADHD samples may also be heterogeneous because childhood
ADHD does not always persist into adulthood [Faraone et al.,
2006; Moffitt et al., 2015]. Thus, to gain better understanding of
the genetic overlap between childhood aggression in aADHD and
oppositional dimensions in cADHD, this relationship should be
examined in larger sample using more rigorous statistical methods,
such as those developed to test specifically for genetic correlation
among various traits [Yang et al., 2011; Bulik-Sullivan et al.,
2015a,b]. This was not possible to implement in the current study
due to our modest sample size.
Examination of previously reported aggressiveness-related GWA
loci revealedmodest commonality in genetic architecture between the
childhood measures of aggressiveness in both cADHD and aADHD,
as well as in CD and anti-social personality disorder (Supplementary
Table SVIII). This observation may be in line with formerly reported
phenotypic overlap between these conditions, although to which
extent this overlap can be transmitted to various subtypes of aggres-
siveness remains to be determined [Storebo and Simonsen, 2013].
This study should be viewed in light of its limitations. One
explanation for not observing any genome-wide significant loci
(P< 5.00E-08) could be our relatively modest sample size and
examination of common variants only (MAF> 1%). This study
had 63% power to detect common variants with small effect size of
explaining 0.5% of variability under an additive model and
an alpha level of 0.05 (http://genome.sph.umich.edu/wiki/
Power_Calculations: Quantitative_Traits). This may also be
observed in the distribution of the QQ plots (Supplementary
Fig. S3).
Another explanation for the lack of significant findings may lay
in phenotypic variability. Clinical heterogeneity may weaken true
association signals due to the use of different assessment protocols
or real genetic heterogeneity among subtypes of ADHD[McClellan
and King, 2010]. There are several methodological caveats to
assessing aggressiveness [Moffitt et al., 2015]. As our samples
consist of outpatients, we investigate a broader and perhaps
“softer” aspect of aggressiveness than say, for example, if we
were to study prison inmates and/or juvenile offenders. However,
this approach provides us with access to the vast majority of
aggressive behaviors, which may not come to be written in official
records [Moffitt, 2005]. Furthermore, we lack assessment of dif-
ferent subtypes of aggressive behavior that may be related to
different genotypes.
Considering the different direction of effects and different
measures of aggression in the cADHD and the aADHD samples,
analyzing the adult samples and the youth sample together could
potentially have obscured the genetic association signal. This is why
we refrained from performing meta-analysis across all samples.
Nonetheless, the WURS includes a host of symptoms related to
various elements of aggressiveness, which, based on our factor
analysis as well as previous research [Ward et al., 1993] seem to be
of key importance to the phenotype of aADHD, and the ODD
measures have also been validated in previous studies of cADHD
[Stringaris et al., 2012; Aebi et al., 2013]. Our approach may add to
the discussion of the Negative Valence System in the Research
Domain Criteria (RDoC) of the National Institute of Mental
Health (NIMH) of how to conceptualize and operationalize
aggressiveness as a dimension across different samples and dis-
orders [Verona and Bresin, 2015; Veroude et al., 2015].
We lacked information on current substance abuse in our
aADHD sample. Substance abuse is known to be frequently
comorbidwithADHDandmay confound the relationship between
ADHD and current aggressiveness. However, we utilized a retro-
spective measure of childhood aggressiveness that is likely to reflect
behavior over a longer period of time and should, thus, be less
affected by volatile environmental influences [Gulberg-Kj€ar and
Johansson, 2009].
Finally, since the genome-wide genotyping arrays consist of
SNPs only, wewere not able to assess the contribution of previously
reported variable tandem repeats (e.g., those in MAOA) that were
noted to be associated with aggressive behaviors and/or ADHD.
Taken together with evidence from previous studies, our results
implicate mechanisms of cell adhesion as well as regulation of gene
expression in the etiology of childhood aggressiveness in ADHD.
As there is a substantial degree of overlap in aggressiveness among
neuropsychiatric disorders, it could be beneficial to analyze
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conditions where aggression is present together in order to pin-
point biological processes in dysfunctional forms of aggressiveness.
Further studies including samples of both children, adolescents and
adults, adopting multimodal measures and longitudinal designs
are warranted. Such studies may help our understanding as to
which extent various subtypes of aggression are mediated by
different mechanisms.
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Hadde du som barn diagnostisert hyperkinetisk lidelse/ADHD? ja  nei  
Tror du selv at du som barn hadde ADHD? ja  nei  
Ble du som barn behandlet med Ritalin eller amfetamin? ja  nei  
Hvis ja, hvor lenge fikk du slik behandling?  _______________
Har du eller har du hatt lese- eller skrivevansker? ja  nei  
Har du eller har du hatt epilepsi? ja  nei  
Har du eller har du hatt migrene? ja  nei  
Har du eller har du hatt astma? ja  nei  
Har du eller har du hatt betydelig angst eller depresjon? ja  nei  
Har du eller har du hatt autisme, tics, Tourettes eller Aspergers syndrom? ja  nei  
Har du eller har du hatt psykisk utviklingshemming? ja  nei  
Har du bipolar eller manisk depressiv lidelse? ja  nei  
Har du eller har du hatt problem med alkohol? ja  nei  
Har du prøvd andre rusmidler? ja  nei  
Har du eller har du hatt problem med andre rusmidler? ja  nei  
Har du eller har du hatt annen psykisk lidelse? ja  nei  
Har du fått behandling for annen psykisk lidelse enn ADHD? ja  nei   
Har du eller har hatt spiseforstyrrelse (bulimi, anorexia nervosa)? ja  nei   
Er det noen blant dine foreldre, søsken eller barn som har eller har hatt:
hyperkinetisk lidelse/ADHD? ja  nei  usikker  
lese- eller skrivevansker? ja  nei  usikker  
epilepsi? ja  nei  usikker  
migrene? ja  nei  usikker  
astma? ja  nei  usikker  
betydelig angst eller depresjon? ja  nei  usikker  
autisme, tics, Tourettes eller Aspergers syndrom? ja  nei  usikker  
psykisk utviklingshemming? ja  nei  usikker  
bipolar (manisk depressiv) lidelse? ja  nei  usikker  
problem med alkohol? ja  nei  usikker  
problem med andre rusmidler? ja  nei  usikker  
annen psykisk lidelse? ja  nei  usikker  
ADHD-prosjektet   KGJebsen-senteret, Universitetet i Bergen, Jonas Lies vei 91, 5009 Bergen   Tlf: 55 58 68 48   E-post: adhdprosjekt@psybp.uib.no   http://adhdprosjektet.b.uib.no
SPØRRESKJEMA FOR PASIENT 















Evt. annen opprinnelse: 
_______________________ 
_______________________
Personnummer:     _________________________________________
Sett ring rundt det tallet som best mulig beskriver din atferd i løpet av de siste 6 måneder
1. Hvor ofte gjør du ubetenksomme feil når du må  arbeide med en kjedelig eller vanskelig oppgave? 0 1 2 3 4
2.
Hvor ofte har du vansker med å opprettholde  
oppmerksomheten når du utfører kjedelig arbeid  
eller arbeid som innebærer gjentakelser?
0 1 2 3 4
3. Hvor ofte har du vansker med å konsentrere deg om  hva andre sier til deg, selv om de snakker direkte til deg? 0 1 2 3 4
4.
Hvor ofte har du vansker med å få gjort ferdig de siste  
detaljer  av en oppgave, når den utfordrende delen er  
gjennomført?
0 1 2 3 4
5.
Hvor ofte har du vansker med å få plassert saker i riktig  
rekkefølge når du arbeider med oppgaver som krever  
organisering?
0 1 2 3 4
6.
Når du har en oppgave som krever mye gjennom-
tenkning, hvor ofte unngår eller utsetter du å begynne 
med den?
0 1 2 3 4
7. Hvor ofte har du forlagt eller har vansker med å finne igjen ting hjemme eller på jobben? 0 1 2 3 4
8. Hvor ofte distraheres du av aktiviteter og støy rundt deg? 0 1 2 3 4
9. Hvor ofte har du vanskeligheter med å huske avtaler eller forpliktelser? 0 1 2 3 4
10. Når du må sitte stille over en lengre tid, hvor ofte beveger  du hender eller føtter på en urolig eller rastløs måte? 0 1 2 3 4
11. Hvor ofte må du forlate din plass i møter eller andre  situasjoner, hvor det forventes at du blir sittende? 0 1 2 3 4
12. Hvor ofte føler du deg rastløs eller urolig? 0 1 2 3 4
13. Hvor ofte har du vansker med å koble ut og slappe av  når du har tid til deg selv? 0 1 2 3 4
14. Hvor ofte føler du deg overaktiv og tvunget til å gjøre ting, som om du var drevet av en motor? 0 1 2 3 4
15. Hvor ofte opplever du at du snakker for mye i sosiale  situasjoner? 0 1 2 3 4
16. Når du deltar i en samtale, hvor ofte fullfører du andres  setninger før de selv kan gjøre det? 0 1 2 3 4
17. Hvor ofte har du vansker med å vente på at det er din  tur i situasjoner hvor det forventes at man venter på tur? 0 1 2 3 4















































Aldri      Sjelden    Av og til     Ofte     Veldig ofte
August 2011
Som barn var jeg/hadde jeg (sett ring rundt det tallet som passer best):
1. Konsentrasjonsproblemer, lett å distrahere 0 1 2 3 4
2. Engstelig, bekymret 0 1 2 3 4
3. Nervøs, urolig 0 1 2 3 4
4. Uoppmerksom, dagdrømmende 0 1 2 3 4
5. Hissig temperament, ble lett sint 0 1 2 3 4
6. Raserianfall 0 1 2 3 4
7. Problemer med å holde seg til en aktivitet,  fullførte ikke det en hadde begynt på 0 1 2 3 4
8. Sta, sterk viljestyrke 0 1 2 3 4
9. Trist, deprimert, ikke glad 0 1 2 3 4
10. Ulydig, uforskammet, frekk 0 1 2 3 4
11. Dårlig selvbilde 0 1 2 3 4
12. Irritabel 0 1 2 3 4
13. Humørsyk, humøret svingte ofte 0 1 2 3 4
14. Sint 0 1 2 3 4
15. Vanskelig for å se ting fra andres synsvinkel 0 1 2 3 4
16. Handlet uten å tenke, var impulsiv 0 1 2 3 4
17. Tendens til å være umoden 0 1 2 3 4
18. Plaget av skyldfølelse og anger 0 1 2 3 4
19. Lett for å miste kontrollen over meg selv 0 1 2 3 4
20. Tendens til å være, eller oppføre meg irrasjonelt 0 1 2 3 4
21. Upopulær blant andre barn, hadde bare venner for  en kort stund, kom dårlig overens med andre barn 0 1 2 3 4
22. Trøbbel med autoriteter, problemer på skolen,  ble sendt til rektor 0 1 2 3 4
23. Lite flink, lærte sent 0 1 2 3 4
24. Problemer med matematikk eller tall 0 1 2 3 4
25. Fikk aldri vist hva jeg kunne klare 0 1 2 3 4
Ikke i det hele tatt  
el. bare litt
Av og til En del Nokså mye Veldig mye
August 2011
Søvn og søvnproblemer
1. Har du i løpet av livet hatt en periode på en måned eller mer der du har hatt søvnproblemer?   Ja     Nei
2. Har du noen gang benyttet reseptbelagt(e) sovemedisin(er)?   Ja     Nei
3.  Hvor ofte har du i løpet av de siste 4 ukene sovnet uten at du ville det eller måtte kjempe for å holde deg 
våken på dagtid?
 Aldri     Noen ganger     Vanligvis (mesteparten av tiden)     Alltid (hele tiden)
4.  Hvor ofte har du i løpet av de siste 4 ukene hatt urolige eller maurende følelser i beina om kvelden eller 
natten, og som ble bedre av bevegelse?
 Aldri     Noen ganger     Vanligvis (mesteparten av tiden)     Alltid (hele tiden)
5.  Kjenner du til (eventuelt gjennom andre) om du i løpet av de siste 4 ukene har hatt gjentatte rykninger 
eller bevegelser i beina i søvne?
 Aldri     Noen ganger     Vanligvis (mesteparten av tiden)     Alltid (hele tiden)
6.  Kjenner du til (eventuelt gjennom andre) om du i løpet av de siste 4 ukene har snorket høyt? 
 Aldri     Noen ganger     Vanligvis (mesteparten av tiden)     Alltid (hele tiden)
7.  Kjenner du til (eventuelt gjennom andre) om du i løpet av de siste 4 ukene har hatt pustepauser eller 
stoppet å puste i søvne? 
 Aldri     Noen ganger     Vanligvis (mesteparten av tiden)     Alltid (hele tiden)
8.  Hvor ofte har du i løpet av de siste 4 ukene opplevd plutselig tap av muskelkraft (f.eks. knekk i knærne)  
ved følelsesmessige reaksjoner som f.eks. latter, sinne eller frykt? 
 Aldri     Noen ganger     Vanligvis (mesteparten av tiden)     Alltid (hele tiden)
9. Er du morgen- eller kveldsmenneske?    Utpreget morgenmenneske
        Mer morgen- enn kveldsmenneske 
        Verken eller
        Mer kvelds- enn morgenmenneske
        Utpreget kveldsmenneske
Sett ring rundt det alternativet (antall dager pr. uke) som passer best for deg.  
0 er ingen dager i løpet av en uke, 7 er alle dager i løpet av en uke. Sett ring rundt ett tall for hvert spørsmål. 
10.  I løpet av den siste måneden, hvor mange dager pr. uke har du brukt 
mer enn 30 minutter for å sovne etter at lysene ble slukket? 0     1     2     3     4     5     6     7
11.  I løpet av den siste måneden, hvor mange dager pr. uke har du vært 
våken mer enn 30 minutter innimellom søvnen? 0     1     2     3     4     5     6     7
12.  I løpet av den siste måneden, hvor mange dager pr. uke har du våknet 
mer enn 30 minutter tidligere enn du har ønsket uten å få sove igjen? 0     1     2     3     4     5     6     7
13.  I løpet av den siste måneden hvor mange dager pr. uke har du følt deg 
for lite uthvilt etter å ha sovet? 0     1     2     3     4     5     6     7
14.  I løpet av den siste måneden, hvor mange dager pr. uke har du vært så 
søvnig/trett at det har gått ut over skole/jobb eller privatlivet? 0     1     2     3     4     5     6     7
15.  I løpet av den siste måneden, hvor mange dager pr. uke har du vært 
misfornøyd med søvnen din? 0     1     2     3     4     5     6     7
16. Hvor mye søvn får du gjennomsnittlig per døgn? ____ timer  ____ minutter
17.  Hvordan synes du at du sover totalt sett? (Sett strek under)  
Veldig bra    Ganske bra    Hverken bra eller dårlig    Ganske dårlig    Veldig dårlig
18.  Har det vært spesielle forhold (livssituasjon, helse m.m.) som har påvirket søvnen din siste 4 uker? 
Ja     Nei     Usikker  
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